https://biolegacyresearch.com/bay-areas-sutrovax-scores-64-million-to-tackle-pneumococcal-vaccines/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/onxeo-to-present-data-supporting-three-key-orphan-oncology-assets-at-aacr-annual-meeting/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/4-small-cap-biotechs-to-consider-if-gilead-isnt-doing-it-for-you/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/22nd-century-group-inc-issues-annual-letter-to-shareholders/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/neurocrine-biosciences-announces-publication-of-positive-results-from-kinect-3-phase-iii-study-of-ingrezza-tm-valbenazine-for-the-treatment-of-tardive-dyskinesia/ 2017-03-21T00:00:00+00:00 https://biolegacyresearch.com/fda-center-directors-urge-lawmakers-to-advance-user-fees/ 2017-03-21T22:17:53+00:00 https://biolegacyresearch.com/gmp-violations-result-in-warning-letters-for-two-foreign-manufacturers/ 2017-03-21T22:18:41+00:00 https://biolegacyresearch.com/china-looks-to-change-import-drug-registration-system/ 2017-03-21T22:19:45+00:00 https://biolegacyresearch.com/india-responds-to-drug-quality-concerns-with-electronic-monitoring-plan/ 2017-03-21T22:20:45+00:00 https://biolegacyresearch.com/flagship-biosciences-inc-release-is-pd-l1-harmonization-on-the-horizon/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/5-biotechs-the-super-rich-are-favoring-in-2017-so-far/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/bsterilizb-release-r-d-rapid-disinfector-outperforms-competitive-uv-c-disinfection-system-in-an-independent-study/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/biogens-victory-over-4-billion-ms-patent-spat-makes-company-an-even-more-attractive-ma-target/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/eighth-annual-champions-to-cureduchenne-gala-presented-by-fired-up-charity-foundation-to-be-held-april-8-at-university-of-texas-golf-club/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/5-biotechs-that-have-major-catalysts-coming-in-the-next-6-to-9-months/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/hemovent-files-two-additional-patent-applications-for-its-portable-ecmo-device-for-both-circulatory-and-respiratory-support/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/novartis-ags-phase-iii-drug-for-heart-failure-bombs-trial/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/viking-therapeutics-reports-fourth-quarter-and-year-end-2016-financial-results-and-provides-corporate-update/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/reverse-merger-with-gives-cerulean-execs-a-parting-gift-bonuses/ 2017-03-22T00:00:00+00:00 https://biolegacyresearch.com/woodcock-fda-must-hire-specialists-to-implement-pdufa-vi-21st-century-cures/ 2017-03-22T22:39:34+00:00 https://biolegacyresearch.com/gao-to-investigate-the-fdas-approval-process-for-orphan-drugs/ 2017-03-22T22:40:20+00:00 https://biolegacyresearch.com/sanofi-regeneron-sue-amgen-to-prevent-patent-dispute-over-eczema-drug-dupixent/ 2017-03-22T22:42:37+00:00 https://biolegacyresearch.com/woodcock-aam-testify-on-rems-programs-delaying-generic-competition/ 2017-03-22T22:59:20+00:00 https://biolegacyresearch.com/arrowhead-pharma-adopts-stockholder-rights-agreement/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/teva-backpedals-on-6000-job-cuts-says-figure-is-too-high/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/stanford-university-clinical-geneticist-begins-presidency-with-the/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/rumor-alert-sanofi-close-to-scooping-up-this-massachusetts-biotech-in-1-billion-deal/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/baxter-international-to-host-first-quarter-2017-financial-results-conference-call-for-investors/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-ultragenyx-tanks-as-seizure-drug-flunks-phase-ii-test/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/scientists-use-graphene-to-power-electronic-skin-that-can-feel-university-of-glasgow-study-reveals/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/turns-out-editas-medicines-rd-deal-with-allergan-could-be-worth-1-billion/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/pci-synthesis-wins-big-at-2017-life-science-leader-magazine-cmo-leadership-awards/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-the-super-rich-regret-buying-in-2017-so-far/ 2017-03-23T00:00:00+00:00 https://biolegacyresearch.com/lawmakers-take-investigation-into-emflazas-price-to-new-owner-ptc-therapeutics/ 2017-03-23T22:10:00+00:00 https://biolegacyresearch.com/bio-two-drugmakers-side-with-amgen-in-biosimilar-case/ 2017-03-23T22:12:00+00:00 https://biolegacyresearch.com/mhra-lists-most-common-errors-in-clinical-trial-applications/ 2017-03-23T22:16:00+00:00 https://biolegacyresearch.com/fda-posts-draft-guidance-for-drugs-to-prevent-kidney-delayed-graft-function/ 2017-03-23T22:47:00+00:00 https://biolegacyresearch.com/blue-earth-diagnostics-receives-positive-opinion-for-axumin-fluciclovine-18f-for-pet-imaging-of-recurrent-prostate-cancer/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/googles-mysterious-biotech-calico-forms-a-rare-deal-with-c4-therapeutics/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/verastem-reports-year-end-2016-financial-results/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/theranos-ceo-gives-up-own-shares-to-investors-to-avoid-being-sued/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/bbi-solutions-dr-consider-international-standards-for-cancer-biomarkers/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/despite-recent-layoffs-eli-lilly-to-invest-850-million-in-u-s-operations/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/eleven-bio-reports-fourth-quarter-and-full-year-2016-financial-results/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/googles-verily-employees-make-themselves-at-home-at-onyxs-former-hq/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/syneron-medical-announces-availability-of-its-annual-report-on-form-20-f-through-its-website/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/how-this-new-jersey-biotech-is-taking-on-amgen/ 2017-03-24T00:00:00+00:00 https://biolegacyresearch.com/house-fails-to-pass-aca-repeal-bill/ 2017-03-24T22:52:40+00:00 https://biolegacyresearch.com/fda-warning-letters-to-foreign-facilities-soar-in-2017/ 2017-03-24T22:53:34+00:00 https://biolegacyresearch.com/ema-requests-suspending-sales-of-hundreds-of-drugs-due-to-flawed-data-from-indian-cro/ 2017-03-24T22:54:38+00:00 https://biolegacyresearch.com/ema-recommends-eu-approval-for-six-drugs-including-three-orphan-drugs/ 2017-03-24T22:55:27+00:00 https://biolegacyresearch.com/proqr-therapeutics-b-v-appoints-as-chief-development-strategy-officer/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/ge-healthcare-to-invest-500-million-and-hire-5000-software-engineers/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/icad-wins-fda-approval-for-powerlook-tomo-detection/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/filings-reveal-concert-pharma-spurned-250-million-buyout-offer-from-vertex-in-november-2016/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/10x-genomics-launches-first-high-throughput-solution-for-adaptive-immune-system-analysis-at-single-cell-resolution/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/neotract-inc-s-minimally-invasive-urolift-system-for-enlarged-prostate-now-shown-to-be-durable-through-five-years-results-from-pivotal-l-i-f-t-randomized-study-presented/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnsons-100000-anti-burnout-program-for-top-execs/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/bavivab-invests-in-owlstone-medical-breath-biopsy-platform/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/media-mogul-dumps-125-million-theranos-stake-for-1/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/these-two-drugmakers-have-even-more-debt-than-valeant/ 2017-03-27T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-meets-with-senate-health-committee-chairman-ahead-of-confirmation-hearings/ 2017-03-27T22:29:53+00:00 https://biolegacyresearch.com/industry-ema-needs-to-focus-on-real-world-evidence-for-tracking-pharmacovigilance/ 2017-03-27T22:30:51+00:00 https://biolegacyresearch.com/fda-places-divis-facility-on-import-alert/ 2017-03-27T22:31:58+00:00 https://biolegacyresearch.com/fda-cites-zs-pharma-over-testing-validation-problems/ 2017-03-27T22:33:06+00:00 https://biolegacyresearch.com/cryoport-announces-proposed-public-offering-of-common-stock/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/belon-muskb-launches-neuroscience-startup-to-plug-ai-into-your-brain/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/bantoine-papiernikb-appointed-chairman-of-bsofinnova-partnersb/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/while-3-way-bids-go-on-stada-arzneimittel-ceos-car-is-bugged-received-photos-of-himself-in-personal-or-private-biz-situations/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/single-cell-technology-company-dolomite-bio-celebrates-a-successful-first-year/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/fda-clears-massachusetts-biotech-tesaros-ovarian-cancer-parp-inhibitor/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/invivo-therapeutics-announces-seventh-patient-conversion-in-the-inspire-study-of-the-neuro-spinal-scaffold/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/never-say-never-why-taking-out-bristol-myers-squibb-could-boost-pfizers-value-by-5-billion/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/newron-pharma-shareholders-confirm-company-management/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/questions-arise-over-the-worlds-richest-doctors-breakthrough-cancer-therapy-promo-videos/ 2017-03-28T00:00:00+00:00 https://biolegacyresearch.com/mccaskill-requests-documents-sales-pitches-from-five-top-opioid-manufacturers/ 2017-03-28T22:06:59+00:00 https://biolegacyresearch.com/fda-to-begin-ora-reorganization-in-mid-may/ 2017-03-28T22:47:11+00:00 https://biolegacyresearch.com/celltrion-files-challenges-to-four-genentech-patents/ 2017-03-28T23:33:03+00:00 https://biolegacyresearch.com/international-forum-seeks-to-promote-drug-supply-chain-security/ 2017-03-28T23:54:44+00:00 https://biolegacyresearch.com/vertex-consolidating-rd-ops-in-3-locations-shutters-site-in-canada/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/bsgi-dnab-launches-automated-next-generation-sequencing-library-construction-kits-for-the-bioxp-3200-system-to-expand-the-capabilities-of-the-genomic-workstation/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/what-a-day-genentech-lands-fda-approval-for-first-drug-to-treat-severe-multiple-sclerosis/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/providence-medical-technology-snags-new-fda-clearances-for-standalone-use-of-cavux-cervical-cage-l-system-and-ally-facet-screws/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/celgene-stocks-up-on-more-juno-stock-after-failed-flagship-drug-trial/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/varian-medical-systems-schedules-second-quarter-fy2017-news-release-and-conference-call/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/and-it-begins-looks-to-cut-1-2-billion-of-nih-rd-spending-this-year/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/purdue-pharma-l-p-highlights-research-from-multiple-studies-at-managed-care-specialty-pharma-annual-meeting-2017/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-depomed-craters-as-new-ceo-directors-are-named-in-deal-with-activist-investor/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/bliquidmetalb-passes-implant-study/ 2017-03-29T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-to-recuse-himself-from-agency-decisions-on-more-than-20-companies/ 2017-03-29T22:38:50+00:00 https://biolegacyresearch.com/price-says-hhs-trump-developing-plan-to-lower-drug-prices/ 2017-03-29T22:39:40+00:00 https://biolegacyresearch.com/fda-committee-unanimously-recommends-new-subcutaneous-dose-of-rituxan/ 2017-03-29T22:40:28+00:00 https://biolegacyresearch.com/fda-rejects-mylans-generic-advair-anda-after-denying-sandozs-petition/ 2017-03-29T22:41:59+00:00 https://biolegacyresearch.com/chattem-inc-s-xyzal-allergy-24hr-launches-to-otc-market/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/mass-layoffs-hit-ariad-employees-after-takedas-5-2-billion-buyout-deal/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/worldwide-clinical-trials-selects-as-new-head-of-global-business-development/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/top-5-life-science-jobs-for-working-from-home/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/curematch-partnering-with-patient-power-to-educate-and-empower-patients-and-oncologists-regarding-personalized-cancer-treatments/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/tango-therapeutics-officially-debuts-with-55-million-and-a-crew-of-superstar-scientific-advisers/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/integer-ceo-steps-down/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-agenus-to-phase-out-20-of-jobs-shutter-switzerland-facility-in-restructuring/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/tonix-pharma-prices-public-offering-of-1800000-shares-of-common-stock/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/lam-therapeutics-scores-58-million-and-a-new-clinical-program-in-cancer/ 2017-03-30T00:00:00+00:00 https://biolegacyresearch.com/industry-orgs-urge-fda-to-delay-new-quality-metrics-program/ 2017-03-30T22:33:55+00:00 https://biolegacyresearch.com/democrats-propose-broad-drug-price-initiative-including-importation-negotiations-and-transparency/ 2017-03-30T22:35:12+00:00 https://biolegacyresearch.com/fda-reports-to-congress-on-regulatory-science-achievements/ 2017-03-30T22:36:00+00:00 https://biolegacyresearch.com/prometic-life-sci-reports-its-2016-fourth-quarter-and-year-end-highlights-and-financial-results/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-that-could-be-taken-out-this-quarter/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/collplant-provides-commercial-and-operational-update/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-that-may-disappear-by-2020/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/shocker-life-saving-portable-defibrillator-movement-plagued-by-malfunctions/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/former-pfizer-neuroscientist-to-helm-new-york-biotech/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/akers-biosciences-reports-preliminary-unaudited-earnings-highlights-for-fiscal-year-2016/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-ordered-to-hand-over-80000-records-of-sham-events-for-doctors/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/aldeyra-reports-full-year-2016-financial-results/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/worlds-richest-doctors-nanthealth-reports-184-million-loss-for-2016/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/novartis-ags-talent-woes-continue-as-seattle-genetics-poaches-a-top-car-t-exec/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/qiagen-n-v-joins-cancer-id-consortium-for-liquid-biopsy-workflows/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/prolacta-bioscience-names-new-members-and-expands-resources-for-dietitians-and-clinicians/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/akers-biosciences-announces-a-2-million-private-placement/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/repros-therapeutics-reports-fourth-quarter-and-year-end-2016-financial-results/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/livanova-plc-cfo-resigns/ 2017-03-31T00:00:00+00:00 https://biolegacyresearch.com/gao-asks-state-pharmacy-regulators-to-rate-interactions-with-the-fda/ 2017-03-31T22:34:57+00:00 https://biolegacyresearch.com/fda-accepts-novartis-kite-pharmas-personalized-cancer-treatments-for-review/ 2017-03-31T22:36:50+00:00 https://biolegacyresearch.com/fda-warns-singapore-drugmaker-over-validation-labeling-issues/ 2017-03-31T22:37:42+00:00 https://biolegacyresearch.com/anda-applications-could-hit-new-record-in-fiscal-2017/ 2017-03-31T22:38:32+00:00 https://biolegacyresearch.com/vioguard-signs-agreement-with-of-saudi-arabia-to-represent-vioguard-in-the-middle-east/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/4-drug-stocks-with-major-fda-decisions-coming-this-month/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/milliporesigma-introduces-next-generation-high-sensitivity-protein-detection-platform/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/astellas-takes-out-belgium-biotech-in-deal-worth-853-million/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/cipher-pharma-announces-amendment-to-debt-agreement-and-partial-prepayment/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/this-little-known-12-billion-socal-startup-wants-to-cure-baldness-and-smooth-out-your-wrinkles/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/singulex-announces-ce-mark-for-sgx-clarity-system/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-wall-street-predicts-is-heading-toward-tremendous-growth/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/united-therapeutics-announces-decision-from-patent-trial-and-appeal-board-and-issuance-of-new-patents/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/bpresident-trumpsb-right-hand-woman-bkellyanne-conwayb-consulted-for-nations-leading-science-group/ 2017-04-03T00:00:00+00:00 https://biolegacyresearch.com/ema-requests-suspending-sales-of-hundreds-of-drugs-for-flawed-data/ 2017-04-03T16:01:00+00:00 https://biolegacyresearch.com/lawmakers-seek-additional-info-on-fdas-heparin-investigations/ 2017-04-03T16:03:17+00:00 https://biolegacyresearch.com/fda-will-lift-import-alert-on-sun-pharmas-mohahi-facility/ 2017-04-03T16:05:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-flags-gmp-other-compliance-problems/ 2017-04-03T16:08:15+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-three-firms-over-quality-other-violations/ 2017-04-03T16:17:53+00:00 https://biolegacyresearch.com/india-responds-to-drug-quality-concerns-with-electronic-monitoring/ 2017-04-03T16:51:00+00:00 https://biolegacyresearch.com/judge-invalidates-ampyra-patents-clearing-path-for-generics-a-decade-early/ 2017-04-03T22:14:00+00:00 https://biolegacyresearch.com/judge-rules-for-novartis-in-zortress-patent-infringement-suit-with-a-caveat/ 2017-04-03T22:15:52+00:00 https://biolegacyresearch.com/indian-regulators-to-fast-track-who-approved-combination-products-for-hiv-hepatitis/ 2017-04-03T22:18:07+00:00 https://biolegacyresearch.com/fda-cites-gordon-laboratories-over-supplier-evaluations-other-violations/ 2017-04-03T22:19:06+00:00 https://biolegacyresearch.com/democrats-lobby-for-price-transparency-as-senate-continues-user-fee-debates/ 2017-04-04T22:14:15+00:00 https://biolegacyresearch.com/ptab-throws-out-united-therapeutics-remodulin-patent-in-win-for-steadymed/ 2017-04-04T22:15:23+00:00 https://biolegacyresearch.com/fda-warns-supplement-maker-for-misbranding-procedural-violations/ 2017-04-04T22:16:27+00:00 https://biolegacyresearch.com/fda-cites-emcure-for-validation-testing-and-reporting-issues/ 2017-04-04T22:17:00+00:00 https://biolegacyresearch.com/ait-therapeutics-raises-gross-proceeds-of-10-9-million-and-completes-reverse-merger/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/mabvax-therapeutics-presents-two-posters-at-the-aacr-annual-meeting-on-a-novel-radioimmunotherapy-treatment-for-pancreatic-cancer/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/bparagon-genomicsb-launches-its-cleanplex-target-enrichment-solution-at-aacr-2017/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/valeant-plummets-after-revealing-jaw-dropping-payday-for-its-ceo/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/data-to-be-presented-at-highlighting-genfits-latest-progress-in-nash-biomarker-diagnostics-identifying-novel-compounds-with-potent-antifibrotic-properties-and-illustrating-the-opportunities-in-an/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/unfavorable-ruling-forces-acorda-to-pink-slip-20-of-jobs/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/certara-corporations-partners-with-to-audit-the-nations-medical-countermeasures-preparedness/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/why-really-left-valeant/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/simulations-plus-releases-gastroplus-version-9-5/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/unilife-slashes-workforce-and-may-not-have-enough-cash-to-survive-beyond-this-week/ 2017-04-05T00:00:00+00:00 https://biolegacyresearch.com/international-regulators-release-template-for-assessing-biowaivers/ 2017-04-05T21:08:15+00:00 https://biolegacyresearch.com/celltrion-files-challenges-to-four-of-genentechs-herceptin-patents/ 2017-04-05T21:10:59+00:00 https://biolegacyresearch.com/drugmakers-back-regeneron-sanofi-in-amgen-repatha-patent-case/ 2017-04-05T21:12:40+00:00 https://biolegacyresearch.com/gottlieb-answers-senate-questions-on-upholding-fda-standards/ 2017-04-05T22:11:46+00:00 https://biolegacyresearch.com/in-a-joint-meeting-advisory-committees-recommend-approval-of-abuse-deterrent-opioid/ 2017-04-05T22:12:47+00:00 https://biolegacyresearch.com/ny-attorney-general-joins-kickbacks-lawsuit-against-astrazeneca-subsidiary/ 2017-04-05T22:13:40+00:00 https://biolegacyresearch.com/fda-hits-otsuka-facility-for-cleaning-equipment-maintenance-problems/ 2017-04-05T22:14:29+00:00 https://biolegacyresearch.com/ceapro-reports-2016-financial-results-and-provides-corporate-update/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/look-out-biotech-googles-parent-sets-sights-on-poaching-top-talent-from-life-sciences-and-healthcare/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/biotronik-release-new-icd-lead-with-helical-design-now-launched-in-europe/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/how-artificial-life-spawned-a-billion-dollar-industry/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/new-device-could-quickly-assess-brain-bleeding-in-head-injuries-reveals/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/pharma-giant-merck-co-considering-600-job-it-hub-in-austin/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/ferring-pharma-highlights-progress-on-social-and-environmental-goals-in-corporate-social-responsibility-csr-review-2015-2016/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-regenerons-evinacumab-a-breakthrough/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/ajinomoto-appoints-as-vice-president-of-compliance/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/novogen-terminates-preclinical-program-will-cut-an-undisclosed-number-of-jobs/ 2017-04-06T00:00:00+00:00 https://biolegacyresearch.com/ema-guidance-lists-sponsor-requirements-for-completing-periodic-safety-reports/ 2017-04-06T22:36:01+00:00 https://biolegacyresearch.com/march-sees-new-surge-of-nearly-200-submitted-andas/ 2017-04-06T22:36:52+00:00 https://biolegacyresearch.com/fda-hits-aurobindo-for-computer-controls-documentation-issues/ 2017-04-06T22:37:50+00:00 https://biolegacyresearch.com/spineguard-raises-2-million-of-fresh-equity-finance/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/sanofi-genzyme-exec-exits-to-become-cmo-of-flexionmdashsanofis-rumored-buyout-target/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/medtronic-confirms-recall-of-its-stratamr-adjustable-valves-and-shunts/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/takeda-splits-off-a-range-of-businesses-to-focus-on-rd/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/intec-pharma-reports-2016-fourth-quarter-and-full-year-financial-results/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-forges-peptide-discovery-pact-worth-1-5-billion-with-japanese-biopharma-peptidream/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/keystone-nano-announces-start-of-clinical-testing-of-ceramide-nanoliposome-for-the-improved-treatment-of-cancer/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/fda-finally-allows-23andme-to-sell-at-home-dna-tests-for-10-diseases/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/intralytix-receives-fda-regulatory-clearance-for-phage-based-shigella-technology/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/gilead-quietly-starts-recruiting-employees-for-china-expansion/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/si-bone-announces-published-guidance-recommendation-for-minimally-invasive-si-joint-fusion-from-the-si-bone/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/nemaura-pharma-appoints-as-director-of-strategic-alliances/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/researchers-create-new-diagnostic-tool-for-detecting-breast-cancer-simon-fraser-university-study-reveals/ 2017-04-07T00:00:00+00:00 https://biolegacyresearch.com/cdrh-priorities-focus-on-data-quality/ 2017-04-07T20:47:38+00:00 https://biolegacyresearch.com/fda-grants-marketing-approval-for-first-direct-to-consumer-genetic-tests/ 2017-04-07T20:48:54+00:00 https://biolegacyresearch.com/new-eu-mdr-offers-major-compliance-hurdles/ 2017-04-07T20:49:47+00:00 https://biolegacyresearch.com/uks-mhra-releases-new-guidance-on-virtual-manufacturing/ 2017-04-07T20:50:39+00:00 https://biolegacyresearch.com/cooperation-not-confrontation-key-to-internal-audits/ 2017-04-07T20:51:55+00:00 https://biolegacyresearch.com/denttio-draws-warning-for-complaint-evaluations-capa/ 2017-04-07T20:52:52+00:00 https://biolegacyresearch.com/483-round-up-design-validations-other-issues-noted-at-four-companies/ 2017-04-07T20:54:04+00:00 https://biolegacyresearch.com/fda-postpones-ectd-requirements-for-drug-master-files-by-one-year/ 2017-04-07T21:59:37+00:00 https://biolegacyresearch.com/fda-rejects-mercks-request-to-add-cardiovascular-safety-data-to-januvias-label/ 2017-04-07T22:00:25+00:00 https://biolegacyresearch.com/patent-office-upholds-shires-patent-for-hunter-syndrome-enzyme-replacement-therapy/ 2017-04-07T22:01:21+00:00 https://biolegacyresearch.com/phrma-backs-fda-plan-to-improve-distribution-of-inspection-information/ 2017-04-07T22:02:15+00:00 https://biolegacyresearch.com/bswalwellb-leads-call-for-fda-to-help-life-science-start-ups-navigate-regulatory-process/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/and-hes-back-medivations-to-helm-axovant/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/mindchild-medical-inc-announces-publication-of-evaluation-of-the-fetal-qt-interval-using-non-invasive-fetal-ecg-technology-with-the-meridian-fetal-monitoring-system/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/3-drug-giants-that-boasts-the-best-pipelines/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/xbiotech-announces-additions-to-its-scientific-advisory-board/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/these-3-big-biotechs-could-have-new-blockbuster-drugs-very-soon/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/enxray-raises-2-3-million-to-fund-commercial-launch/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/biohaven-eyes-100-million-ipo-to-bankroll-trials-of-shelved-astrazeneca-plc-bristol-myers-squibb-drugs/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/bioverativ-appoints-executive-vice-president-research-and-development/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/finally-stada-arzneimittel-accepts-5-6-billion-takeover-offer-from-cinven/ 2017-04-10T00:00:00+00:00 https://biolegacyresearch.com/maryland-legislature-sends-generic-drug-price-gouging-bill-to-governor/ 2017-04-10T21:47:21+00:00 https://biolegacyresearch.com/gsk-seeks-supreme-court-ruling-on-paxil-suit-jurisdiction/ 2017-04-10T21:47:46+00:00 https://biolegacyresearch.com/federal-judge-orders-propranolol-generic-price-fixing-lawsuit-to-proceed/ 2017-04-10T21:48:16+00:00 https://biolegacyresearch.com/immunex-files-patent-infringement-complaint-against-sanofi-regeneron/ 2017-04-10T21:48:47+00:00 https://biolegacyresearch.com/adaptimmune-announces-closing-of-42-million-registered-direct-offering/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-startup-frequency-therapeutics-nabs-32-million/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/invo-bioscience-appoints-renowned-fertility-specialist-to-its-board-of-directors/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/bsecb-cracks-down-on-fake-biotech-news/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/cryolife-announces-release-date-and-teleconference-call-details-for-2017-first-quarter-financial-results/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/strike-it-rich-with-these-3-biotech-stocks-that-have-late-stage-drugs/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/alere-achieves-fda-clearance-for-alere-reader-platform-and-alere-binaxnow-influenza-a-b-card-2/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/bay-area-avinger-cuts-workforce-by-33/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/wolters-kluwer-nv-provides-multilingual-workflow-integrated-patient-education-for-meditech-ehr-users/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/its-official-bioptix-names-new-ceo/ 2017-04-11T00:00:00+00:00 https://biolegacyresearch.com/fda-warns-mylan-facility-over-quality-and-data-issues/ 2017-04-11T22:16:25+00:00 https://biolegacyresearch.com/class-action-suit-claims-actavis-teva-and-taro-fixed-prices-of-generic-fluocinonide-cream/ 2017-04-11T22:17:36+00:00 https://biolegacyresearch.com/federal-appeals-court-affirms-sun-pharmas-generic-prevacid-following-takeda-patent-suit/ 2017-04-11T22:19:00+00:00 https://biolegacyresearch.com/fda-hits-guardian-drug-for-lack-of-quality-controls-secure-data/ 2017-04-11T22:21:33+00:00 https://biolegacyresearch.com/shutdown-looming-unilife-files-for-chapter-11/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/why-these-3-drugmakers-could-buy-incyte/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/definiens-ag-to-host-international-symposium-for-tissue-phenomics/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/wait-for-it-tapped-congressman-to-become-the-next-drug-czar/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/simplify-medical-inc-announces-first-patient-treated-in-u-s-pivotal-trial-of-mri-optimized-simplify-cervical-artifical-spinal-disc-used-at-two-adjacent-levels/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/its-official-ovid-ceo-just-filed-for-86-million-ipo/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/bmedical-device-innovation-consortiumb-announces-brachael-l-fleurenceb-ph-d-appointed-as-executive-director-of-the-bnational-evaluation-system-for-health-t/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/why-this-bay-area-biotech-stock-grew-415-in-the-last-year/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/the-verdict-is-in-conmeds-surgiquest-liable-for-2-2-million-in-compensatory-damages/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/bostons-puretech-gives-birth-to-new-biotech-and-its-name-is/ 2017-04-12T00:00:00+00:00 https://biolegacyresearch.com/uk-regulator-accuses-actavis-concordia-of-delaying-competition-to-fix-prices/ 2017-04-12T21:25:49+00:00 https://biolegacyresearch.com/ema-requests-suspending-hundreds-of-drugs-over-indian-cro-data-flaws/ 2017-04-12T21:27:09+00:00 https://biolegacyresearch.com/fda-grants-new-rmat-designation-humacyte-vascular-tissue-therapy/ 2017-04-12T21:39:22+00:00 https://biolegacyresearch.com/white-house-tells-fda-and-other-agencies-to-prepare-for-staff-cuts-as-hiring-freeze-ends/ 2017-04-12T22:17:38+00:00 https://biolegacyresearch.com/fda-hits-indoco-on-quality-control-responses-to-1500-complaints/ 2017-04-12T22:19:13+00:00 https://biolegacyresearch.com/ema-publishes-draft-guideline-on-complying-with-clinical-trial-master-file-requirements/ 2017-04-12T22:20:07+00:00 https://biolegacyresearch.com/tga-urges-drugmakers-to-focus-on-data-integrity/ 2017-04-12T22:21:20+00:00 https://biolegacyresearch.com/ligand-to-report-first-quarter-2017-results-on-may-9th/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/tech-giant-apple-hires-secret-team-of-biomedical-engineers-for-treating-diabetes/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/guided-therapeutics-ships-five-luviva-advanced-cervical-scans-to-chinese-partner/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/top-10-best-innovative-pharma-companies-to-work-for/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/for-a-german-medical-device-startup-the-road-to-being-acquired-went-through-houston/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-inks-two-separate-pacts-with-biogen-and-roche-for-a-total-of-up-to-1-1b/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/abiomed-fourth-quarter-fiscal-2017-earnings-and-conference-call-notification/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/its-not-over-yet-stays-mum-on-plans-for-new-biotech-software-company/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/aimmune-appoints-as-chief-financial-officer/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/bostons-sv-life-sciences-unveils-name-change-debuts-400m-fund-for-biotech/ 2017-04-13T00:00:00+00:00 https://biolegacyresearch.com/ema-revises-guidance-on-clinical-data-publication-policy/ 2017-04-13T22:48:11+00:00 https://biolegacyresearch.com/teva-receives-second-fda-warning-letter-in-six-months-for-international-facilities/ 2017-04-13T22:48:54+00:00 https://biolegacyresearch.com/shire-division-asks-court-to-dismiss-ftc-suit-over-citizen-petitions/ 2017-04-13T22:49:45+00:00 https://biolegacyresearch.com/creative-peptides-shortened-their-supply-turnaround-time/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/how-boston-scientific-is-getting-drug-eluting-stents-and-balloons-into-legs/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/fda-just-rejected-eli-lilly-incytes-rheumatoid-arthritis-drug-baricitinib/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/american-gene-technologies-international-announces-as-chief-financial-officer/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/pharma-giant-merck-sharp-dohme-could-bring-600-new-jobs-to-austin/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/medovex-corporation-retains-cg-capital-as-investor-relations-counsel/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/2-drugmakers-seek-to-block-arkansas-from-using-their-drugs-to-execute-7-men/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/cytokinetics-to-announce-first-quarter-results-on-april-27-2017/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-leading-the-pack-in-the-hepatitis-b-space/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/is-medtronics-artificial-pancreas-the-next-big-thing-in-diabetes/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/sartorius-stedim-biotech-presents-the-first-fully-integrated-upstream-platform/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/glaukos-acquires-iop-sensor-system-from/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/vapourtec-expands-with-new-headquarters-and-plans-for-job-creation/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/medicrea-releases-first-quarter-sales-for-2017/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/youll-want-to-own-this-biotech-stock-in-the-next-market-crash/ 2017-04-14T00:00:00+00:00 https://biolegacyresearch.com/congress-unveils-fda-user-fee-reauthorization-package/ 2017-04-14T22:11:37+00:00 https://biolegacyresearch.com/novartis-loses-patent-on-billion-dollar-ms-drug-following-circuit-court-appeal/ 2017-04-14T22:12:28+00:00 https://biolegacyresearch.com/fda-dings-cook-pharmica-on-inadequate-testing-anti-contamination-protection/ 2017-04-14T22:13:22+00:00 https://biolegacyresearch.com/fda-import-alert-leaves-who-without-a-source-for-birth-control-api/ 2017-04-14T22:14:20+00:00 https://biolegacyresearch.com/amniox-medical-obtains-federal-supply-schedule-contract-for-neox-and-clarix-product-lines/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/when-it-rains-it-pours-bay-areas-oncomed-tanks-again-as-lung-cancer-med-fails-phase-ii-discontinues-phase-i-study/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/pressure-biosciences-inc-appoints-as-vice-president-of-finance-and-chief-financial-officer/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/how-biogen-lost-its-chance-to-be-the-hunter-and-became-the-hunted-in-just-a-few-months/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/innoviva-board-recommends-shareholders-vote-for-all-of-s-qualified-directors-on-the-white-proxy-card/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/perrigo-shakes-up-exec-roster-and-board-hands-out-a-fistful-of-pink-slips/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/3d-printed-patch-can-help-mend-a-broken-heart-university-of-minnesota-study-reveals/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/new-biotech-incubator-emerges-in-washington-aims-to-create-jobs-and-hub-outside-of-seattle/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/intersect-ent-to-report-first-quarter-2017-financial-results/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/bthe-ministry-of-health-and-preventionb-organizes-second-emirates-international-conference-on-combating-drug-counterfeiting/ 2017-04-17T00:00:00+00:00 https://biolegacyresearch.com/companies-urge-fda-to-develop-guidance-on-combination-product-reviews/ 2017-04-17T21:56:38+00:00 https://biolegacyresearch.com/jazz-settles-seven-year-xyrem-patent-case-with-hikma-granting-license-for-2023/ 2017-04-17T21:57:24+00:00 https://biolegacyresearch.com/fda-hits-glatt-on-equipment-cleaning-quarantining-procedures/ 2017-04-17T22:09:00+00:00 https://biolegacyresearch.com/public-citizen-survey-only-four-drugmakers-commit-to-single-digit-price-increases/ 2017-04-17T22:12:00+00:00 https://biolegacyresearch.com/court-rules-in-favor-of-on-majority-of-allegations-in-proposed-class-action-lawsuit/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-remains-hush-hush-about-car-t-trial-but-the-fda-is-impressed-and-thinks-its-a-breakthrough/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/bspirax-sarcob-to-speak-at-the-food-automation-and-manufacturing-conference-2017/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/cancer-biotech-g1-therapeutics-files-for-115-million-ipo/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/keryx-to-host-conference-call-of-first-quarter-2017-financial-results-on-thursday-may-4-2017/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/how-pfizer-made-most-of-its-52-8-billion-last-year/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/theranos-reach-agreement-on-full-restitution-to-state-consumers/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/hanmi-pharma-charged-for-failure-to-report-patient-death-in-olmutinib-study/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/adocia-announces-first-quarter-2017-financial-results/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-pushes-a-nash-combo-into-late-stage-development-with-a-little-help-from-its-friend-allergan/ 2017-04-18T00:00:00+00:00 https://biolegacyresearch.com/fda-warns-targeted-medical-for-misbranding-a-drug-as-medical-food/ 2017-04-18T22:17:37+00:00 https://biolegacyresearch.com/more-drugmakers-pursuing-non-competitive-research-partnerships-deloitte-says/ 2017-04-18T22:19:08+00:00 https://biolegacyresearch.com/mhra-finds-increasing-trend-of-sterility-deficiencies/ 2017-04-18T22:26:44+00:00 https://biolegacyresearch.com/abbott-reports-first-quarter-2017-results/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-hosts-shark-tank-like-competition-and-crowned-this-biotech-startup-as-its-winner/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/socals-usgi-medical-names-former-conmed-exec-as-ceo/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/fdas-shorten-review-time-is-a-bad-sign-for-puma-biotechs-controversial-cancer-drug/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/crown-bioscience-launches-e-commerce-platform-to-commercialize-its-life-science-products/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/its-officially-the-end-of-the-road-for-massachusetts-biotech-nuclea-biotechnologies/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/bdetact-diagnosticsb-receives-2-1-million-investment-from-nom-finance/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/why-former-medivation-ceo-and-a-once-failed-alzheimers-drug-could-be-a-recipe-for-disaster-for-axovant/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/targovax-invitation-to-first-quarter-2017-results-presentation-tuesday-25-april/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/googles-verily-launches-10000-person-study-to-create-a-map-of-human-health/ 2017-04-19T00:00:00+00:00 https://biolegacyresearch.com/senate-help-committee-sets-date-for-vote-on-gottliebs-fda-nomination/ 2017-04-19T22:29:19+00:00 https://biolegacyresearch.com/calif-prosecutor-sues-boehringer-teva-over-aggrenox-pay-for-delay-agreement/ 2017-04-19T22:30:00+00:00 https://biolegacyresearch.com/ema-work-plan-targets-priority-drug-review-program/ 2017-04-19T22:31:20+00:00 https://biolegacyresearch.com/fda-hits-aesica-over-quality-controls-record-keeping/ 2017-04-19T22:32:00+00:00 https://biolegacyresearch.com/ppd-heroes-advocate-for-clinical-research-to-improve-patient-health/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/bay-area-startup-offers-a-compelling-deal-to-scientists-hunting-for-new-drugs/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/verilys-baseline-homemade-wearable-and-limited-data-sharing/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/abbvies-parp-inhibitor-fails-to-deliver-in-two-late-stage-studies/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/oxford-immunotec-schedules-first-quarter-2017-earnings-release-and-conference-call-for-may-2-2017/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-atara-biotherapeutics-leases-huge-space-in-socal/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/arkis-biosciences-expands-clinical-use-of-its-new-minimally-invasive-tunneling-guidewire-technology/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/3-intriguing-small-cap-biotechs-to-put-on-your-watchlist/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/foundation-medicine-inc-announces-timing-for-first-quarter-2017-financial-results-and-conference-call/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/exec-reveals-sanofi-is-hunting-for-mas-to-boost-diabetes-biz/ 2017-04-20T00:00:00+00:00 https://biolegacyresearch.com/cder-adds-gaucher-disease-to-2017-guidance-agenda/ 2017-04-20T22:33:31+00:00 https://biolegacyresearch.com/drugmakers-request-revisions-to-draft-guidance-on-sharing-information-with-payors/ 2017-04-20T22:39:29+00:00 https://biolegacyresearch.com/fdas-off-label-communications-guidance-needs-more-clarity-industry-says/ 2017-04-20T22:43:27+00:00 https://biolegacyresearch.com/five-prime-to-announce-first-quarter-2017-financial-results-and-host-conference-call-on-may-4/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/why-90-of-this-26-billion-biotechs-sales-could-be-at-risk-within-the-next-2-years/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/lonza-group-unveils-agendia-bv-for-3rd-annual-global-endotoxin-testing-summit/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/2-biotech-players-to-keep-your-eye-on/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/pfizer-invites-public-to-listen-to-webcast-of-april-27-annual-meeting-of-shareholders/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/no-doubt-this-is-the-top-gene-sequencing-stock-to-buy-this-year/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/pfizer-unveils-atlas-an-interactive-user-friendly-website-that-provides-global-antibiotic-resistance-surveillance-data-across-60-countries/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-hires-bank-of-america-to-officially-review-alcon-options/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/aduro-biotech-announces-management-promotions/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/investors-accuse-theranos-of-threatening-to-file-for-bankruptcy-if-they-didnt-give-up-their-right-to-sue/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/alkermes-to-host-conference-call-to-discuss-first-quarter-2017-financial-results/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/gene-radar-authorized-for-zika-testing-interview-with-nanobiosym-founder-and-ceo/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/cannimed-announces-voting-results-of-agm-for-the-election-of-directors/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/scynexis-inc-to-host-a-conference-call-to-discuss-lead-anti-infective-candidate-scy-078-data-presented-at/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/innoviva-to-report-first-quarter-financial-results-on-april-27-at-500-p-m-edt/ 2017-04-21T00:00:00+00:00 https://biolegacyresearch.com/fdas-unapproved-use-communication-rules-prompt-first-amendment-worries/ 2017-04-21T22:21:08+00:00 https://biolegacyresearch.com/mhra-outlines-regulatory-goals-in-preparation-for-leaving-the-eu/ 2017-04-21T22:22:13+00:00 https://biolegacyresearch.com/fda-approves-second-remicade-biosimilar-samsung-bioepis-renflexis/ 2017-04-21T22:23:01+00:00 https://biolegacyresearch.com/emas-chmp-recommends-11-medicines-for-approval-including-three-biosimilars/ 2017-04-21T22:23:47+00:00 https://biolegacyresearch.com/fda-allows-in-vitro-studies-to-demonstrate-naloxone-bioequivalence/ 2017-04-21T22:24:36+00:00 https://biolegacyresearch.com/fda-orders-texas-arizona-to-destroy-their-execution-drugs/ 2017-04-24T22:14:12+00:00 https://biolegacyresearch.com/sanofi-sues-mylan-over-business-practices-blocking-its-epipen-competitor/ 2017-04-24T22:15:00+00:00 https://biolegacyresearch.com/apotex-urges-the-fda-to-require-testing-of-biosimilars-on-intended-patient-population/ 2017-04-24T22:16:09+00:00 https://biolegacyresearch.com/gottlieb-avoids-written-commitments-to-recusal-for-22-companies/ 2017-04-24T22:56:47+00:00 https://biolegacyresearch.com/bbenevirb-granted-patent-protecting-lead-oncolytic-immunotherapy-stealth-1h-and-other-platform-assets/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/embattled-marathon-pharma-may-shutter-operations-by-may-1/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/eagle-pharma-to-discuss-first-quarter-2017-financial-results-on-may-8-2017/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/why-this-socal-pharma-could-be-your-best-bet-on-alzheimers/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/personalis-receives-approval-from-for-clinical-tests-based-on-the-ace-exome/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/germanys-fresenius-kabi-ag-slams-down-4-3-billion-for-akorn-in-u-s-expansion/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/beclinical-solutions-llcb-appoints-new-vice-president-of-biostatistics/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/rumor-mill-johnson-johnson-novartis-ag-and-takeda-are-all-making-googly-eyes-at-this-brazilian-drugmaker/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/contravir-announces-pricing-of-public-offering-of-common-stock-and-warrants/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/epimab-biotherapeutics-raises-25m-in-series-a-financing-from-international-consortium-to-advance-pipeline-of-novel-bispecific-antibodies/ 2017-04-25T00:00:00+00:00 https://biolegacyresearch.com/scotus-hears-arguments-over-the-jurisdiction-for-bms-plavix-cases/ 2017-04-25T22:10:00+00:00 https://biolegacyresearch.com/pfizer-genentech-warn-against-requiring-impractical-switching-studies-for-biosimilar-interchangeability/ 2017-04-25T22:11:26+00:00 https://biolegacyresearch.com/divis-draws-warning-over-gmp-problems/ 2017-04-25T22:12:00+00:00 https://biolegacyresearch.com/fourteen-companies-land-fda-warnings-for-false-cancer-claims/ 2017-04-25T22:13:25+00:00 https://biolegacyresearch.com/exactech-q1-revenue-up-6-to-69-5-million-on-21-extremities-growth/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/and-so-it-begins-covance-cuts-100-employees-in-shut-down/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/tesaro-to-announce-first-quarter-2017-financial-results-on-may-9-2017/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/dropping-revenue-expect-more-cuts-and-closures-as-labcorp-aligns-covance-biz/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/macrogenics-announces-date-of-first-quarter-2017-financial-results-conference-call/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/some-predict-biogens-alzheimers-drug-will-fail/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/resmed-unveils-the-worlds-smallest-sleep-apnea-device-for-travelers/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/why-high-flying-ma-target-tesaro-recently-lost-more-than-a-quarter-of-its-value/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/inovio-pharma-to-report-first-quarter-2017-financial-results-may-10-2017/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/otsuka-pharma-believes-in-akebia-commits-another-865-million-to-expand-anemia-deal/ 2017-04-26T00:00:00+00:00 https://biolegacyresearch.com/supreme-court-to-decide-on-180-day-biosimilar-exclusivity-early-notification/ 2017-04-26T21:58:23+00:00 https://biolegacyresearch.com/gottlieb-confirmation-vote-delayed/ 2017-04-26T21:59:28+00:00 https://biolegacyresearch.com/tga-scraps-15-day-gmp-clearance-timeline-expands-to-30-days/ 2017-04-26T22:00:12+00:00 https://biolegacyresearch.com/ema-should-clarify-role-in-collaboration-on-non-eu-drugs-officials-say/ 2017-04-26T22:01:07+00:00 https://biolegacyresearch.com/macrogenics-announces-registered-direct-offering-of-common-stock/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-dumps-two-drugs-from-pipeline-causing-an-ex-partners-stock-to-tank-some-more/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/genkyotex-s-a-provides-business-update-for-q1-2017/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/mark-your-calendars-4-biotechs-facing-fda-decision-dates-in-may/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/arrowhead-pharma-to-webcast-fiscal-2017-second-quarter-results/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/top-10-rd-scientist-skills-in-demand/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/zogenix-to-release-first-quarter-2017-financial-results-and-host-conference-call-and-webcast-on-may-4/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/the-biotech-job-title-youve-probably-never-heard-of/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/pfizer-hosts-annual-meeting-of-shareholders/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/another-biotech-is-born-as-bay-areas-bridgebio-pharma-launches-with-27-million/ 2017-04-27T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-nomination-moves-on-to-full-senate/ 2017-04-27T21:49:08+00:00 https://biolegacyresearch.com/petition-calls-for-sentinel-query-on-off-label-use-of-ulcer-drug/ 2017-04-27T21:50:00+00:00 https://biolegacyresearch.com/house-senate-re-introduce-bill-targeting-generic-drug-suppression/ 2017-04-27T21:51:14+00:00 https://biolegacyresearch.com/congress-averts-shutdown-for-now/ 2017-04-28T21:15:38+00:00 https://biolegacyresearch.com/transparency-initiatives-spread-as-companies-acknowledge-rising-drug-costs/ 2017-04-28T21:16:45+00:00 https://biolegacyresearch.com/fda-warns-american-specialty-pharmacy-for-adulteration/ 2017-04-28T21:17:39+00:00 https://biolegacyresearch.com/fda-approves-label-changes-for-anesthetics-in-young-children/ 2017-04-28T21:18:32+00:00 https://biolegacyresearch.com/sinovac-biotech-ltd-reports-announces-filing-extension-for-2016-annual-report/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/tiny-parion-sciences-seals-dry-eye-drug-deal-worth-535-million-with-biotech-giant-shire/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/syndax-to-announce-first-quarter-2017-financial-results-and-host-conference-call-and-webcast-on-may-8-2017/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/why-ma-hungry-sanofi-could-be-gearing-up-to-buy-sarepta/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/curis-to-release-first-quarter-2017-financial-results-and-hold-conference-call-on-may-4-2017/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/takedas-5-billion-bet-on-ariad-pays-off-with-accelerated-approval-of-lung-cancer-med/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/synergy-pharma-to-highlight-new-data-for-trulance-plecanatide-at/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/gene-editing-leader-horizon-discovery-to-go-on-global-hiring-spree/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/marrone-bio-innovations-inc-closes-9-2-million-public-offering-of-common-stock-with-full-exercise-of-over-allotment-option/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/forward-pharma-cfo-and-two-vps-step-down-will-cut-more-jobs-bringing-the-number-of-full-time-employees-to-seven/ 2017-05-01T00:00:00+00:00 https://biolegacyresearch.com/congress-proposes-modest-increase-for-fda-in-five-month-spending-bill/ 2017-05-01T22:22:52+00:00 https://biolegacyresearch.com/u-s-trade-rep-cites-china-india-over-weak-ip-protections/ 2017-05-01T22:23:57+00:00 https://biolegacyresearch.com/pfizer-files-for-patent-office-review-of-three-biogen-claims-for-rituxan/ 2017-05-01T22:25:14+00:00 https://biolegacyresearch.com/fda-hits-suzhou-amerigen-for-inadequate-investigations-quality-controls/ 2017-05-01T22:26:05+00:00 https://biolegacyresearch.com/celyad-grants-to-novartis-ag-a-non-exclusive-license-for-its-allogeneic-tcr-deficient-car-t-cells-patents/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-that-have-surged-150-during-trumps-first-100-days/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/cambrex-corporation-to-announce-first-quarter-2017-financial-results-on-may-4-2017/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-hits-milestone-with-approval-of-potential-bladder-cancer-blockbuster/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/biologictx-announces-first-year-international-transplantation-successes-utilizing-matchgrid/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/theranos-quietly-settles-lawsuits-with-one-of-its-biggest-investors/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/neos-therapeutics-to-host-first-quarter-2017-financial-results-conference-call-on-may-9-2017/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/on-a-roll-magenta-therapeutics-nabs-another-50-million-a-drug-from-novartis-ag-and-deal-with/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/lakepharma-initiates-key-technology-resource-networks/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/bcongressb-ignores-btrumpb-the-nih-will-get-2-billion-boost-despite-proposed-cuts/ 2017-05-02T00:00:00+00:00 https://biolegacyresearch.com/ema-lists-sponsor-requirements-for-periodic-safety-reports/ 2017-05-02T20:01:11+00:00 https://biolegacyresearch.com/mhra-includes-gmp-quality-in-its-top-priorities/ 2017-05-02T20:03:09+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-slaps-facilities-on-data-integrity-quality/ 2017-05-02T20:04:15+00:00 https://biolegacyresearch.com/key-elements-for-a-successful-internal-audit/ 2017-05-02T20:05:33+00:00 https://biolegacyresearch.com/tga-urges-sponsors-to-focus-on-data-integrity-scraps-15-day-clearance/ 2017-05-02T20:07:10+00:00 https://biolegacyresearch.com/firms-urge-fda-to-develop-guidance-on-combination-product-reviews/ 2017-05-02T20:08:03+00:00 https://biolegacyresearch.com/483-round-up-fda-hits-four-facilities-for-testing-cleaning-procedural-issues/ 2017-05-02T20:09:01+00:00 https://biolegacyresearch.com/fda-warns-api-maker-sal-pharma-over-gmps-following-import-alert/ 2017-05-02T21:51:16+00:00 https://biolegacyresearch.com/fda-nih-publish-harmonized-template-for-late-phase-clinical-trial-protocols/ 2017-05-02T21:52:13+00:00 https://biolegacyresearch.com/fda-cites-syrmiseag-over-capa-violations-records/ 2017-05-02T21:53:13+00:00 https://biolegacyresearch.com/ignyta-announces-proposed-public-offering-of-common-stock/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/this-boston-biotech-gets-57-5-million-upfront-2-1-billion-commitment-from-drug-giant-astrazeneca-plc/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/dexcom-reports-first-quarter-2017-financial-results/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/dont-count-us-out-pfizer-hints-at-a-possible-bristol-myers-squibb-deal/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/isogenica-limited-introduces-next-generation-fully-synthetic-human-fab-antibody-fragment-library/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/this-booming-biotech-inks-huge-lease-in-the-east-bay/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/miragen-to-host-conference-call-discussing-first-quarter-2017-corporate-update-and-financial-results/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/genentech-exec-jumps-ship-to-become-cmo-at-gritstone-oncology/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/metabolon-to-establish-metabolomics-lab-in-qatar-to-serve-markets-in-the-middle-east/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/feds-appeared-at-perrigos-hq-with-search-warrants-yesterday/ 2017-05-03T00:00:00+00:00 https://biolegacyresearch.com/house-approves-fiscal-2017-fda-budget/ 2017-05-03T22:19:13+00:00 https://biolegacyresearch.com/ema-working-out-workload-woes-from-brexit/ 2017-05-03T22:20:20+00:00 https://biolegacyresearch.com/doj-raids-perrigo-offices-as-industry-antitrust-investigation-continues/ 2017-05-03T22:21:46+00:00 https://biolegacyresearch.com/senate-help-committee-schedules-may-10-vote-on-fda-user-fees/ 2017-05-03T22:22:00+00:00 https://biolegacyresearch.com/brief/ 2017-05-03T22:24:21+00:00 https://biolegacyresearch.com/inc-research-and-celebrate-clinical-trials-awareness-week-through-release-of-new-educational-animation/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/booming-blueprint-to-expand-into-former-glaxosmithkline-site/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/cti-biopharma-reports-first-quarter-2017-financial-results/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-predicted-to-grow-415-and-more-in-2018/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/apricus-biosciences-announces-corporate-update-and-first-quarter-2017-financial-results-conference-call/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/backed-by-two-drug-powerhouses-gensight-alum-launches-new-biotech-with-40-million/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/minerva-neurosciences-reports-first-quarter-2017-financial-results-and-business-updates/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/this-one-drugmaker-has-paid-dividends-the-past-120-years/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/pra-health-sciences-announces-the-center-for-pediatric-clinical-development/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/pe-firm-in-talks-to-buy-vwr-in-deal-worth-5-billion/ 2017-05-04T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-nomination-moves-forward-with-a-pledge-to-keep-tabs-on-devices/ 2017-05-04T18:31:21+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-issues-warnings-to-four-device-makers/ 2017-05-04T18:35:01+00:00 https://biolegacyresearch.com/south-africas-mcc-issues-draft-guideline-on-quality-manuals/ 2017-05-04T18:35:42+00:00 https://biolegacyresearch.com/brazil-adopts-risk-based-approach-to-inspections/ 2017-05-04T18:36:20+00:00 https://biolegacyresearch.com/483-roundup-fda-targets-eight-device-facilities/ 2017-05-04T18:37:47+00:00 https://biolegacyresearch.com/congress-clears-spending-bill-measure-to-go-to-president/ 2017-05-04T21:41:27+00:00 https://biolegacyresearch.com/ema-seeks-comments-on-its-pk-guideline-for-pediatric-drug-development/ 2017-05-04T21:43:49+00:00 https://biolegacyresearch.com/fda-hits-allegiant-health-for-lapses-in-controls-and-storage/ 2017-05-04T21:44:00+00:00 https://biolegacyresearch.com/celsion-to-hold-first-quarter-2017-financial-results-conference-call-on-friday-may-12-2017/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/stock-soars-as-immunomedics-ceo-coo-exit-and-seattle-genetics-dumps-2-billion-deal/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/zogenix-provides-corporate-update-and-reports-first-quarter-2017-financial-results/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/3-cancer-biotechs-to-watch-at-asco/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/oncolytics-biotech-announces-2017-first-quarter-results/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/charles-river-laboratories-business-is-booming-with-500-positions-open/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/labcorp-completes-acquisition-of/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/conspiracy-theory-did-puma-biotech-exec-resign-because-of-bad-news-ahead/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/five-prime-announces-first-quarter-2017-results-and-provides-business-update/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/its-official-vwr-sold-in-6-4-billion-deal/ 2017-05-05T00:00:00+00:00 https://biolegacyresearch.com/fda-proposes-plan-for-spending-500-million-in-cures-act-funding/ 2017-05-05T21:39:42+00:00 https://biolegacyresearch.com/quintilesims-report-drug-spending-growth-rate-slows-to-5-8-percent-in-2016/ 2017-05-05T21:40:40+00:00 https://biolegacyresearch.com/april-sees-66-anda-approvals-and-112-crls/ 2017-05-05T21:41:36+00:00 https://biolegacyresearch.com/astrazeneca-canada-release-pan-canadian-oncology-drug-review-recommendation-supports-the-use-of-tagrisso-osimertinib-as-the-standard-of-care-for-t790m-mutated-non-small-cell-lung-cancer/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/this-bay-area-biotech-snags-293-million-pain-drug-pact-with-novartis-ag/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/ironwood-provides-first-quarter-2017-investor-update/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/the-worlds-richest-doctor-loses-top-nanthealth-exec/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/bispeb-releases-the-new-cultural-excellence-report/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/catastrophic-year-for-bay-areas-oncomed-continues-as-lead-drug-comes-crashing-down-in-phase-ii-study/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/chromocell-appoints-vice-president-of-clinical-development/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/fast-growing-intarcia-awaits-crucial-fda-decision-in-new-boston-hq/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/lamellar-biomedical-ltd-raises-5-75-million-in-series-c-fund-raising-led-by/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/horizon-pharma-pays-145-million-for-and-its-rare-eye-disease-drug/ 2017-05-08T00:00:00+00:00 https://biolegacyresearch.com/boehringer-ingelheim-teva-sued-over-aggrenox-pay-for-delay-agreement/ 2017-05-08T19:50:18+00:00 https://biolegacyresearch.com/sanofi-sues-mylan-over-blocking-its-epipen-competitor-auvi-q/ 2017-05-08T19:51:10+00:00 https://biolegacyresearch.com/fda-allows-in-vitro-studies-to-prove-generic-naloxone-bioequivalence/ 2017-05-08T19:52:32+00:00 https://biolegacyresearch.com/judge-invalidates-ampyra-patents-clearing-path-for-early-generics/ 2017-05-08T19:54:22+00:00 https://biolegacyresearch.com/apotex-petitions-for-population-testing-ahead-of-biosimilar-approvals/ 2017-05-08T19:55:24+00:00 https://biolegacyresearch.com/pto-upholds-shire-patent-for-elaprase-enzyme-replacement-therapy/ 2017-05-08T19:58:10+00:00 https://biolegacyresearch.com/suit-claims-actavis-teva-taro-fixed-prices-of-fluocinonide-cream/ 2017-05-08T19:59:07+00:00 https://biolegacyresearch.com/fda-cites-api-manufacturer-over-inadequate-records-and-testing/ 2017-05-08T22:07:19+00:00 https://biolegacyresearch.com/six-generics-companies-ask-judge-to-dismiss-price-fixing-suit-brought-by-40-states/ 2017-05-08T22:08:08+00:00 https://biolegacyresearch.com/senator-says-pain-groups-are-too-closely-tied-to-industry-to-talk-opioids/ 2017-05-08T22:09:04+00:00 https://biolegacyresearch.com/ema-to-continue-patient-engagement-efforts-in-assessments/ 2017-05-08T22:35:40+00:00 https://biolegacyresearch.com/oramed-granted-canadian-patent-for-glp-1-analog-capsule/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/takeda-abingworth-infuse-100-million-into-a-tiny-biotech-sealing-an-option-for-ma/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/aquinox-announces-first-quarter-2017-financial-results/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/pfizer-sheds-more-after-unloading-medivations-mission-bay-space/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/trading-in-novo-nordisk-as-shares-by-board-members-executives-and-associated-persons-on-8-may-2017/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/cro-giant-parexel-explores-4-billion-sale-stock-jumps/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/check-cap-reports-first-quarter-2017-financial-results/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/these-2-biotechs-shark-antibodies-have-caught-amgens-eye/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/bc-platforms-closes-usd-10-million-series-b-financing-led-by-debiopharm-and-to-accelerate-knowledge-platform-development/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/ai-firm-exscientia-grabs-eur250-million-small-molecules-pact-with-sanofi/ 2017-05-09T00:00:00+00:00 https://biolegacyresearch.com/msd-and-genentech-settle-pto-dispute-over-cabilly-patent/ 2017-05-09T22:12:46+00:00 https://biolegacyresearch.com/senate-confirms-gottlieb-to-lead-fda/ 2017-05-09T22:16:09+00:00 https://biolegacyresearch.com/fdas-science-board-reviews-agencys-500-million-cures-act-work-plan/ 2017-05-09T22:17:04+00:00 https://biolegacyresearch.com/biosimilars-create-competition-savings-in-eu-markets/ 2017-05-09T22:17:56+00:00 https://biolegacyresearch.com/fda-warns-api-manufacturers-in-india-michigan/ 2017-05-09T22:33:00+00:00 https://biolegacyresearch.com/fda-publishes-draft-revisions-to-prescriber-blueprint-for-long-acting-opioids/ 2017-05-09T22:54:15+00:00 https://biolegacyresearch.com/ignyta-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/genentechs-top-cancer-prospect-flunks-phase-iii-test/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/egalet-reports-first-quarter-2017-financial-results/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/parexel-to-slash-up-to-1200-jobs-worldwide/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/acadia-reports-first-quarter-2017-financial-results/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/its-official-new-fda-head-confirmed/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/ligand-reports-first-quarter-2017-financial-results/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/4-biotechs-that-could-release-stock-shattering-data-soon/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/emergent-biosolutions-unveils-its-expanded-center-for-innovation-in-advanced-development-and-manufacturing-in-baltimore/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/inc-research-gobbles-up-inventiv-health-in-4-6-billion-deal/ 2017-05-10T00:00:00+00:00 https://biolegacyresearch.com/ema-issues-draft-guideline-on-trial-master-file-compliance/ 2017-05-10T21:51:01+00:00 https://biolegacyresearch.com/chmp-ema-should-clarify-gmp-communications-for-non-eu-drugs/ 2017-05-10T21:52:52+00:00 https://biolegacyresearch.com/chmp-recommends-11-medicines-for-approval-including-3-biosimilars/ 2017-05-10T21:53:20+00:00 https://biolegacyresearch.com/ema-unveils-plan-for-collaboration-with-academia/ 2017-05-10T21:55:17+00:00 https://biolegacyresearch.com/fda-import-alert-leaves-who-with-no-source-for-birth-control-api/ 2017-05-10T21:58:00+00:00 https://biolegacyresearch.com/new-membership-criteria-rd-requirements-cut-22-companies-from-phrma-roster/ 2017-05-10T22:29:59+00:00 https://biolegacyresearch.com/senate-committee-pushes-back-user-fee-markup/ 2017-05-10T22:30:56+00:00 https://biolegacyresearch.com/ema-annual-report-lists-27-new-active-substances-highlights-prime-pathway/ 2017-05-10T22:31:50+00:00 https://biolegacyresearch.com/italian-medicines-agency-cites-indian-api-facility-over-gmp-non-compliance/ 2017-05-10T22:32:43+00:00 https://biolegacyresearch.com/tga-seeks-broader-authority-to-penalize-false-drug-advertising/ 2017-05-10T22:33:39+00:00 https://biolegacyresearch.com/becton-dickinson-and-company-prices-offerings-of-2-25-billion-of-common-stock-and-2-25-billion-of-depositary-shares-representing-interests-in-mandatory-convertible-preferred-stock/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/biogen-exec-leaves-to-put-together-and-helm-new-biotech-startup/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/imprimis-announces-first-quarter-2017-financial-results/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-guardant-health-just-snagged-360-million-to-create-cancer-blood-tests/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/agtc-announces-financial-results-and-business-update-for-the-quarter-ended-march-31-2017/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/pfizer-makes-a-545-million-deal-with-another-bay-area-biotech-sangamo/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/reata-pharmaceuticals-inc-announces-first-quarter-2017-financial-and-operating-results/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/stock-falls-as-fda-slaps-warning-on-researcher-studying-ionis-pharmas-ionis-ttrrx/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/lonza-group-announces-the-successful-results-of-the-rights-offering/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/daiichi-sankyo-abandons-6-clinical-programs-in-q1-update/ 2017-05-11T00:00:00+00:00 https://biolegacyresearch.com/senate-committee-advances-fda-user-fee-reauthorization/ 2017-05-11T21:49:31+00:00 https://biolegacyresearch.com/gottlieb-sworn-in-as-fda-commissioner/ 2017-05-11T21:50:25+00:00 https://biolegacyresearch.com/house-ec-committee-pulls-distributors-dea-into-opioid-epidemic-investigation/ 2017-05-11T21:53:12+00:00 https://biolegacyresearch.com/biolife-solutions-inc-announces-q1-2017-financial-results/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/more-rd-fat-is-trimmed-as-biogen-closes-doors-on-uks-convergence-pharma/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/bmvrxb-to-present-outcomes-of-global-clinical-trials-for-arto-system-at-europcr-2017-may-16-17/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/new-yorks-akari-puts-ceo-on-administrative-leave/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/phaserx-reports-first-quarter-2017-financial-results-and-provides-corporate-update/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/socals-capricor-to-reduce-workforce-and-shift-focus-after-discouraging-trial-results/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/neurodigm-uses-tissue-repair-in-an-innovative-nerve-pain-model/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/top-glaxosmithkline-investor-cashes-out-citing-a-weak-pipeline-and-lack-of-strategic-options/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/dyadic-reports-first-quarter-2017-financial-results/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/struggling-xbiotech-quietly-discloses-exec-resignation/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/ascendis-announces-first-quarter-2017-financial-results-conference-call-on-may-23/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/zomedica-announces-first-quarter-2017-financial-results/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/eiger-biopharma-reports-first-quarter-2017-financial-results/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/cel-sci-announces-change-to-the-date-of-its-annual-meeting/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/china-pharma-holdings-reports-first-quarter-2017-financial-results/ 2017-05-12T00:00:00+00:00 https://biolegacyresearch.com/over-60-members-of-congress-urge-cms-to-set-individual-billing-codes-for-biosimilars/ 2017-05-12T21:51:34+00:00 https://biolegacyresearch.com/amgen-defends-neulasta-manufacturing-patent-in-biosimilar-suit-against-coherus/ 2017-05-12T21:52:22+00:00 https://biolegacyresearch.com/celltrion-files-two-additional-petitions-for-pto-review-of-genentechs-herceptin-patents/ 2017-05-12T21:53:11+00:00 https://biolegacyresearch.com/fda-finds-repeat-deficiencies-at-ohio-outsourcer/ 2017-05-12T21:54:07+00:00 https://biolegacyresearch.com/milliporesigma-launches-industrys-first-off-the-shelf-cell-culture-media-for-perfusion-processes/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/biotech-loses-a-legend-founder-and-longtime-ceo-dies-at-71/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/tonix-pharma-reports-first-quarter-2017-financial-results-and-provides-programs-update/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/biogens-cso-quietly-leaves-but-will-still-get-rd-funding-from-the-biotech-giant/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/adma-biologics-inc-provides-corporate-update-and-reports-first-quarter-2017-financial-results/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/seattles-genoa-pharma-banks-62-million-and-names-a-new-ceo-and-cso/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/proqr-therapeutics-b-v-remembers-co-founder-after-his-unexpected-passing/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/safety-concerns-raised-as-ionis-pharmas-inotersen-meets-both-primary-endpoints-in-late-stage-study/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/genfit-convening-notice-to-the-ordinary-and-extraordinary-shareholders-meeting-on-june-16-2017/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/biogen-strikes-120-million-deal-for-remedy-pharmas-stroke-candidate/ 2017-05-15T00:00:00+00:00 https://biolegacyresearch.com/fda-begins-ora-reorganization-into-seven-product-sectors/ 2017-05-15T21:36:00+00:00 https://biolegacyresearch.com/lawmakers-call-for-white-house-action-user-fee-legislation-to-lower-drug-prices/ 2017-05-15T21:38:16+00:00 https://biolegacyresearch.com/european-commission-launches-price-gouging-investigation-into-aspen-pharma/ 2017-05-15T21:39:23+00:00 https://biolegacyresearch.com/cfda-plans-major-reforms-in-approvals-and-clinical-trial-processes/ 2017-05-15T21:40:17+00:00 https://biolegacyresearch.com/astellas-sues-roxane-labs-over-generic-version-of-billion-dollar-cancer-drug-xtandi/ 2017-05-15T21:41:13+00:00 https://biolegacyresearch.com/atossa-genetics-announces-first-quarter-2017-financial-results-and-provides-company-update/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-sues-former-exec-after-glaxosmithkline-poaches-him-away-to-run-its-largest-business/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/veloxis-pharma-announces-financial-results-for-the-first-three-months-of-2017/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/new-fda-heads-first-order-of-business-inspection-staff-reorg-and-lower-drug-prices/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/invo-bioscience-reports-first-quarter-2017-financial-results/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/3-rock-bottom-biotechs-that-big-market-players-are-betting-on/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/invenra-appoints-vice-president-corporate-development/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/with-plans-for-u-s-and-china-manufacturing-plants-athenex-gears-up-for-100-million-ipo/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/cleveland-biolabs-inc-reports-first-quarter-2017-financial-results-and-development-progress/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/new-study-finds-high-prescription-drug-costs-are-not-driving-up-u-s-healthcare-costs/ 2017-05-16T00:00:00+00:00 https://biolegacyresearch.com/in-first-address-as-fda-commissioner-gottlieb-highlights-opioids-drug-pricing/ 2017-05-16T22:23:24+00:00 https://biolegacyresearch.com/fda-cites-florida-drugmaker-for-serious-quality-violations/ 2017-05-16T22:24:00+00:00 https://biolegacyresearch.com/jjs-blockbuster-diabetes-drug-invokana-receives-boxed-warning-over-amputation-risk/ 2017-05-16T22:26:23+00:00 https://biolegacyresearch.com/fda-issues-21-new-product-specific-draft-guidances-for-generics-16-revised/ 2017-05-16T22:27:30+00:00 https://biolegacyresearch.com/eleven-senate-democrats-warn-proposed-cuts-will-hurt-cures-act-implementation/ 2017-05-16T22:52:48+00:00 https://biolegacyresearch.com/opening-of-digital-innovation-lab-underscores-syngenta-ag-commitment-to-innovation/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/spotted-in-the-bay-area-former-fda-head-in-talks-to-join-googles-verily/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/morphosys-ag-reports-outcome-of-annual-general-meeting-2017/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/confident-johnson-johnson-flexes-its-muscles-plans-10-blockbuster-approvals-by-2021/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/lysogene-reinforces-its-management-team-with-the-nomination-of-as-chief-operating-officer/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/fda-slaps-clinical-hold-on-concert-pharmas-hair-loss-drug/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/bmel-mont-medicalb-announces-the-development-of-ma-by-xytotest-a-self-collected-cervical-sample-that-seeks-to-eradicate-cervical-cancer/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/cancer-biotech-g1-therapeutics-grabs-105-million-in-ipo/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/enzymotec-reports-first-quarter-2017-unaudited-financial-results/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/why-pfizer-may-need-another-big-ma-for-growth/ 2017-05-17T00:00:00+00:00 https://biolegacyresearch.com/hhs-pushes-for-late-in-the-game-user-fee-changes-congress-says-too-late/ 2017-05-17T22:22:33+00:00 https://biolegacyresearch.com/merck-upsher-smith-settle-17-year-pay-for-delay-class-action-suit-for-60-2-million/ 2017-05-17T22:23:32+00:00 https://biolegacyresearch.com/health-canada-proposes-updates-to-drug-pricing-framework/ 2017-05-17T22:24:22+00:00 https://biolegacyresearch.com/ema-updates-guidance-for-sponsors-seeking-postmarket-scientific-advice/ 2017-05-17T22:25:14+00:00 https://biolegacyresearch.com/alabama-repackager-warned-over-misbranding/ 2017-05-17T22:26:09+00:00 https://biolegacyresearch.com/capital-increase-in-bavarian-nordic-as-a-result-of-employee-warrant-exercise/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/teva-cuts-another-500-jobs-may-hire-ceo-who-isnt-israeli/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/arqule-to-present-clinical-data-at-the-2017-asco-annual-meeting/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/former-sarepta-ceo-emerges-to-helm-newly-launched-25-million-biotech-startup-accelerator/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/mediwound-announces-changes-to-its-board-of-directors/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/glycomimetics-stock-takes-off-on-positive-phase-ii-leukemia-data-breakthrough-tag/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/medtronic-resolute-onyx-2-0-mm-clinical-study-meets-primary-endpoint-in-extra-small-vessels-at-one-year/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/genentech-will-pass-out-more-cash-to-researchers-to/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/bepicore-bionetworks-inc-b-reports-quarter-three-results-for-fiscal-year-2017-for-the-quarter-ended-31-march-2017-in-u-s-dollars/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/swedish-orphan-ab-elocta-approved-in-the-kingdom-of-saudi-arabia-for-the-treatment-of-haemophilia-a/ 2017-05-18T00:00:00+00:00 https://biolegacyresearch.com/house-panel-amends-advances-fda-user-fee-bill/ 2017-05-18T22:01:36+00:00 https://biolegacyresearch.com/hhs-delays-340b-overcharging-penalties-until-october/ 2017-05-18T22:04:00+00:00 https://biolegacyresearch.com/ptab-strikes-abbvie-humira-patent-following-coherus-challenge/ 2017-05-18T22:04:51+00:00 https://biolegacyresearch.com/5-biotechs-releasing-highly-anticipated-data-at-asco/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/company-profile-for-laurus-labs/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-to-shed-another-500-jobs-add-350-high-tech-jobs/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/veracyte-announces-anthem-coverage-for-the-afirma-gene-expression-classifier-for-use-in-thyroid-cancer-diagnosis/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/star-rd-duo-nabs-65-million-for-iterum-to-develop-shelved-pfizer-antibiotic/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/buniversity-of-denverb-libraries-select-byewnob-discover-research-application/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/apple-ceo-spotted-wearing-a-prototype-glucose-tracker-on-the/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/this-chicago-startups-google-cardboard-like-device-is-helping-athletes-diagnose-concussions/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/caladrius-biosciences-closes-the-sale-of-its-remaining-interest-in-pct-to-hitachi-chemical-co-ltd-for-75-million/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/argenx-announces-full-exercise-of-underwriters-option-to-purchase-additional-adss/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/mckesson-reports-fiscal-2017-fourth-quarter-and-full-year-results/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/laurus-labs-pat-grows-by-40-board-recommends-a-dividend-of-15/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/stryker-and-allosource-announce-collaboration-to-distribute-biologics-for-use-in-sports-medicine-procedures/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/polyphor-announces-successful-end-of-phase-ii-meeting-with-fda-for-murepavadin-in-nosocomial-pneumonia/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/pharmamar-announces-new-data-with-its-compounds-yondelis-and-lurbinectedin-during-asco-2017/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/two-nih-sources-reveal-is-considering-new-cuts-to-biomedical-research/ 2017-05-19T00:00:00+00:00 https://biolegacyresearch.com/former-gottlieb-colleagues-offer-clues-to-his-management-style-goals/ 2017-05-19T21:00:06+00:00 https://biolegacyresearch.com/janssen-sues-samsung-bioepis-to-block-remicade-biosimilar/ 2017-05-19T21:00:57+00:00 https://biolegacyresearch.com/chmp-recommends-11-medicines-for-approval-including-four-biosimilars/ 2017-05-19T21:02:13+00:00 https://biolegacyresearch.com/fda-warns-drugmaker-on-postmarket-paperwork-problems/ 2017-05-19T21:03:05+00:00 https://biolegacyresearch.com/fda-finds-quality-void-at-california-compounder/ 2017-05-19T21:03:58+00:00 https://biolegacyresearch.com/bausch-lomb-introduces-renu-advanced-formula-multi-purpose-solution/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/these-3-biotechs-could-lead-the-next-biotech-boom/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/gangagen-inc-to-present-new-preclinical-data-on-p128-at-american-society-of-microbiology-microbe-2017/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/amgen-faces-setback-as-osteoporosis-drug-is-linked-to-serious-heart-side-effects/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/actelion-provides-an-update-on-the-progress-towards-launching-key-results-for-pipeline-assets-to-be-developed-by/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/bill-melinda-gates-foundation-bets-on-this-biotech-to-win-the-zika-race-hint-its-a-unicorn/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/bclearsightb-announces-sale-of-parent-company-sharklet-technologies/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-offloads-heart-drugs-to-recordati-in-300-million-deal-to-pump-up-rd/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/china-biologic-products-announces-effectiveness-of-registration-statement-and-mailing-of-definitive-proxy-statementprospectus-for-2017-annual-meeting-of-stockholders/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-bouncing-back-after-a-tough-2016/ 2017-05-22T00:00:00+00:00 https://biolegacyresearch.com/ema-sets-november-launch-date-for-new-eudravigilance-reporting-system/ 2017-05-22T21:46:03+00:00 https://biolegacyresearch.com/drugmakers-seek-clarifications-of-fdas-interchangeability-guidance/ 2017-05-22T21:47:15+00:00 https://biolegacyresearch.com/labels-paperwork-a-long-term-problem-for-arizona-compounder/ 2017-05-22T21:48:10+00:00 https://biolegacyresearch.com/revised-ema-guidance-on-active-substances-takes-effect/ 2017-05-22T21:49:07+00:00 https://biolegacyresearch.com/bflowjo-llcb-launches-cloud-platform-for-multi-omics-experiments/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/merck-co-is-looking-to-hire-many-scientists-at-bio-in-san-diego/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/enteromedics-surges-on-buyout/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/massive-fda-and-nih-cuts-in-outlined-budget-plan/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/juno-appoints-to-board-of-directors/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/market-just-got-more-crowded-as-regeneron-sanofis-new-ra-drug-wins-fda-approval/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/seegene-enters-the-u-s-diagnostic-market-in-collaboration-with-thermo-fisher-scientific/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/former-biogen-exec-launches-first-life-sciences-fund-with-750-million/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-june-23-2017/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/pfizer-alums-banks-45-million-series-c/ 2017-05-23T00:00:00+00:00 https://biolegacyresearch.com/trump-proposes-recalibration-of-fda-budget-with-854-million-in-cuts/ 2017-05-23T21:52:00+00:00 https://biolegacyresearch.com/gottlieb-establishes-opioid-committee-pledges-to-limit-prescription-abuse/ 2017-05-23T21:53:41+00:00 https://biolegacyresearch.com/scotus-rules-patent-lawsuits-may-only-be-filed-where-defendants-are-incorporated/ 2017-05-23T21:54:49+00:00 https://biolegacyresearch.com/keytruda-receives-first-oncology-approval-based-on-tumor-genetics-not-organ-site/ 2017-05-23T21:55:46+00:00 https://biolegacyresearch.com/fda-issues-warning-on-water-borne-contaminant/ 2017-05-23T21:56:53+00:00 https://biolegacyresearch.com/fda-warns-chinese-api-manufacturer-over-quality-management-record-keeping/ 2017-05-23T21:57:45+00:00 https://biolegacyresearch.com/novartis-ag-to-lay-off-250-nationwide-with-204-from-new-jersey-u-s-headquarters/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/3-biopharma-stocks-billionaire-money-managers-unloaded-recently/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/alnylam-announces-proposed-public-offering-of-common-stock/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/how-alexion-is-making-so-much-cash-with-a-drug-that-treats-less-than-11000-patients/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/colorado-state-university-and-synaptive-medical-collaborate-to-better-detect-brain-tumors/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/acelity-launches-prevena-duo-incision-management-system-platform-the-first-single-use-negative-pressure-wound-therapy-npwt-system-for-the-simultaneous-management-of-two-incisions/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/oncolytics-biotech-prices-public-offering-of-units/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/takeda-showcases-broadened-oncology-portfolio-through-data-presentations-at-upcoming-medical-meetings/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/silicon-valley-vcs-quietly-hiring-biotech-experts/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/26-patients-dead-after-replacing-controller-for-abbotts-heartmate-ii-blood-pumps-at-home/ 2017-05-24T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-faces-questions-from-lawmakers-about-the-trump-budgets-impact-on-fda/ 2017-05-24T22:06:00+00:00 https://biolegacyresearch.com/fda-committee-endorses-treatments-for-breast-cancer-sickle-cell-disease/ 2017-05-24T22:07:41+00:00 https://biolegacyresearch.com/ema-issues-guideline-for-reporting-clinical-trial-protocol-breaches/ 2017-05-24T22:08:56+00:00 https://biolegacyresearch.com/weight-loss-drug-commercial-draws-fda-ire/ 2017-05-24T22:10:23+00:00 https://biolegacyresearch.com/mccaskill-grills-mallinckrodt-over-pricing-of-opioid-alternative/ 2017-05-24T22:11:15+00:00 https://biolegacyresearch.com/editors-note-2/ 2017-05-25T20:58:01+00:00 https://biolegacyresearch.com/fda-lifts-hiring-freeze-gottlieb-lays-out-agency-priorities/ 2017-05-25T21:05:00+00:00 https://biolegacyresearch.com/fda-committee-recommends-hospiras-epogenprocrit-biosimilar-for-approval/ 2017-05-25T21:07:57+00:00 https://biolegacyresearch.com/supplement-company-draws-warning-over-gmps/ 2017-05-25T21:09:31+00:00 https://biolegacyresearch.com/mri-interventions-announces-13-25-million-private-placement/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/5-big-pharmas-facing-catalysts-in-2017/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/puma-biotech-receives-fda-advisory-committee-support-for-neratinib/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/how-much-juno-spent-on-its-failed-car-t-drug/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/sanuwave-announces-shock-wave-scientific-program-in-milan-italy-conducted-by-26-may-2017/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/senseonics-prices-41-million-underwritten-offering-of-common-stock/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/recipharm-ab-makes-strategic-appointment-in-the-uk-ireland/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/new-fda-head-lifts-hiring-freeze-takes-aim-at-the-next-and-marathon-pharma/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/one-to-watch-how-bedfont-scientific-is-changing-the-future/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/journalist-sues-fda-for-documents-related-to-sareptas-dmd-drug/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/biogen-loses-yet-another-top-exec/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/fda-advisory-committee-recommends-approval-of-pfizers-proposed-biosimilar-to-epogenprocrit-across-all-indications/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/blexington-biosciencesb-introduces-president-and-board-chair/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/kalytera-therapeutics-announces-changes-to-its-board-of-directors/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/elekta-radiosurgery-solutions-highlighted-at/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/zymeworks-announces-partial-exercise-of-over-allotment-option-for-its-initial-public-offering/ 2017-05-26T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-fields-questions-on-drug-compounding/ 2017-05-29T21:40:00+00:00 https://biolegacyresearch.com/three-states-move-forward-on-drug-pricing-legislation/ 2017-05-29T21:41:00+00:00 https://biolegacyresearch.com/merck-and-optum-to-develop-value-based-drug-pricing-agreements/ 2017-05-29T21:42:00+00:00 https://biolegacyresearch.com/drugmaker-warned-for-lack-of-product-testing/ 2017-05-29T21:43:00+00:00 https://biolegacyresearch.com/can-fite-biopharma-reports-first-quarter-2017-financial-results-provides-clinical-update/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/investors-antsy-as-novartis-ag-mulls-over-selling-50-billion-in-assets/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/vedanta-biosciences-granted-u-s-patent-broadly-covering-methods-of-treatment-with-therapeutics-based-on-bacterial-spore-fractions-of-microbiota-obtained-from-human-donors/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/cambridge-biotech-enumeral-biomedical-has-cash-to-fund-its-operations-only-into-next-month/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/bharvard-pilgrimb-signs-outcomes-based-contracts-with-astrazeneca-plc-for-brilinta-and-bydureon/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/why-june-could-be-a-pivotal-month-for-these-2-biotechs/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/zealand-pharma-increases-its-share-capital-as-a-consequence-of-exercise-of-employee-warrants/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/why-this-tiny-socal-biopharma-could-be-a-real-threat-to-mylan/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/array-biopharma-and-bristol-myers-squibb-announce-strategic-collaboration/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/germanys-evotec-ag-plans-to-hire-scientists-and-execs-at-new-u-s-hq/ 2017-05-30T00:00:00+00:00 https://biolegacyresearch.com/texas-pharmacy-warned-for-using-domperidone/ 2017-05-30T19:49:00+00:00 https://biolegacyresearch.com/amgen-sues-the-fda-over-marketing-exclusivity-for-sensipar-in-pediatric-patients/ 2017-05-30T21:45:00+00:00 https://biolegacyresearch.com/ema-accepts-five-drugs-for-priority-medicine-program/ 2017-05-30T21:46:00+00:00 https://biolegacyresearch.com/emas-pharmacovigilance-committee-recommends-label-changes/ 2017-05-30T21:48:00+00:00 https://biolegacyresearch.com/cure-pharma-and-announce-research-collaboration-with-on-cancer-fighting-cannabinoids/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/akari-ceo-abruptly-steps-down-amid-investigation-into-phase-ii-trial-data/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/bapceth-biopharmab-appoints-bdusan-kosijerb-as-chief-financial-officer/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/spectacular-data-posted-for-novartis-ags-next-generation-car-t-drug/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-may-31-2017/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/a-look-at-gileads-possible-new-drug-strategy/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/compugen-ltd-provides-update-on-com701-and-upcoming-presentations/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/vancouvers-zymeworks-to-hire-an-additional-45-employees-by-the-end-of-2017/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/forward-pharma-appeals-the-initial-decision-in-the-u-s-patent-interference-to-the-federal-circuit/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/crispr-editas-medicine-and-intellia-fall-as-scientific-paper-warns-of-unintended-mutations-linked-to-gene-editing/ 2017-05-31T00:00:00+00:00 https://biolegacyresearch.com/ema-answers-drugmakers-brexit-questions-on-transfers-and-relocations/ 2017-05-31T22:28:48+00:00 https://biolegacyresearch.com/hhs-estimates-mylan-overcharged-1-27-billion-for-the-epipen-over-a-decade/ 2017-05-31T22:29:31+00:00 https://biolegacyresearch.com/ema-unveils-action-plan-to-support-small-and-medium-sized-companies/ 2017-05-31T22:30:20+00:00 https://biolegacyresearch.com/fda-approves-first-strattera-generic-for-adhd-plus-five-other-first-time-generics/ 2017-05-31T22:31:15+00:00 https://biolegacyresearch.com/drugmaker-warned-over-long-term-quality-problems/ 2017-05-31T22:32:03+00:00 https://biolegacyresearch.com/collegium-announces-additional-managed-care-coverage-for-xtampza-er-for-medicare-part-d-patients/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/7-biotechs-and-pharmas-that-have-the-potential-to-double-or-more/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/crown-bioscience-showcases-dramatic-proficiency-in-pdx-models-and-emerging-expertise-in-immune-oncology/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-lays-out-rd-game-plan-at-meet-and-greet-with-30-execs-in-boston/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/bjeffrey-zondermanb-joins-bredshift-bioanalyticsb-as-its-chief-commercial-officer/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/bicycle-therapeutics-snags-52-million-to-take-early-stage-drugs-into-clinic/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/colonaryconcepts-sells-its-novel-colonoscopy-preparation-assets-to-a-gi-focused-specialty-pharma-company/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/founding-ceo-of-editas-medicine-lands-new-gig-at-top-biotech-vc-firm/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/trevena-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-deciphera-banks-52-million-to-advance-oncology-pipeline/ 2017-06-01T00:00:00+00:00 https://biolegacyresearch.com/scotus-decision-on-printer-cartridges-could-impact-drug-imports/ 2017-06-01T22:32:04+00:00 https://biolegacyresearch.com/ohio-becomes-second-state-to-sue-opioid-manufacturers/ 2017-06-01T22:32:57+00:00 https://biolegacyresearch.com/cleanroom-problems-found-in-california-pharmacy-inspection/ 2017-06-01T22:33:45+00:00 https://biolegacyresearch.com/doj-to-review-slap-on-the-wrist-enforcement-of-opioid-manufacturers-distributors/ 2017-06-02T21:33:00+00:00 https://biolegacyresearch.com/pfizer-launches-its-own-challenge-to-genentechs-herceptin-patent-following-celltrion-mylan/ 2017-06-02T21:34:32+00:00 https://biolegacyresearch.com/express-scripts-claims-profiteering-in-suit-against-overdose-treatment-manufacturer/ 2017-06-02T21:35:02+00:00 https://biolegacyresearch.com/belcher-pharma-petitions-fda-to-alter-epinephrine-warning-label/ 2017-06-02T21:36:23+00:00 https://biolegacyresearch.com/incyte-release-combination-of-epacadostat-plus-keytruda-pembrolizumab-demonstrates-activity-in-clinical-trial-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/cambridges-30-person-to-dissolve-this-week/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/janssen-rd-release-data-at-asco-show-consistent-progression-free-survival-benefit-in-relapsedrefractory-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-patients-treated-with-ibrutinib/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/new-immuno-onco-deal-with-merck-kgaa-could-make-this-uk-biotech-a-1-billion-company/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/tg-therapeutics-announces-follow-up-data-from-the-chemo-free-triple-combination-of-tg-1101-tgr-1202-and-ibrutinib-at-the-53rd-annual-meeting-of-the-asco/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/innate-pharma-regroups-from-trial-failure-with-euro410-million-deal-for-novo-nordisk-ass-antic5ar-antibody/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/novocure-release-health-care-service-corporation-issues-positive-coverage-decision-for-optune/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/loxo-oncology-seeks-fda-approval-after-breakthrough-drug-larotrectinib-helped-almost-everyone-who-took-it/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/zymeworks-presents-safety-and-anti-tumor-activity-data-from-the-ongoing-phase-i-study-of-zw25-at-asco-annual-meeting-asco-2017/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/investors-sigh-with-relief-as-bluebird-bio-celgenes-car-t-candidate-keeps-multiple-myeloma-patients-relapse-free/ 2017-06-05T00:00:00+00:00 https://biolegacyresearch.com/nevadas-vetoed-insulin-cost-transparency-bill-returns-as-california-advances-several-pricing-measures/ 2017-06-05T21:34:00+00:00 https://biolegacyresearch.com/gsk-and-viiv-healthcare-use-130-million-priority-review-voucher-to-expedite-hiv-therapy/ 2017-06-05T21:36:03+00:00 https://biolegacyresearch.com/janssen-sues-biosimilar-maker-celltrion-over-its-remicade-manufacturing-patent/ 2017-06-05T21:37:00+00:00 https://biolegacyresearch.com/fda-cites-repeat-offender-over-sterility-gmps/ 2017-06-05T21:38:09+00:00 https://biolegacyresearch.com/zipline-medical-secures-12-million-in-new-financing-led-by-new-investor/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/pe-firms-take-out-new-yorks-amri-for-922-million-cash/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/clarify-medical-core-technology-receives-fda-clearance/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/bramaswamyb-launches-another-new-biotech-to-work-on-phase-iii-ready-drug-from-merck-co/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/axovant-strengthens-executive-team-with-key-management-appointments/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/novan-lays-off-20-of-workforce-switches-up-c-suite/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/bsaintycob-introduces-portable-mini-fluid-bed-granulator-and-coater-for-labs-rd/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/bay-area-grails-billion-gamble-on-the-perfect-cancer-test/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/delcath-systems-announces-adjournment-of-annual-meeting-meeting-scheduled-to-reconvene-on-june-16/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/acorda-jumps-as-parkinsons-drug-performs-well-in-late-stage-study/ 2017-06-06T00:00:00+00:00 https://biolegacyresearch.com/fda-starts-ora-shift-toward-better-focus-stricter-inspections/ 2017-06-06T16:36:28+00:00 https://biolegacyresearch.com/fy-2018-budget-request-a-recalibration/ 2017-06-06T16:37:32+00:00 https://biolegacyresearch.com/as-gottlieb-takes-the-helm-at-fda-expect-focus-on-workforce/ 2017-06-06T16:39:00+00:00 https://biolegacyresearch.com/get-audit-ready-with-internal-checklists-gmp-expert-says/ 2017-06-06T16:46:18+00:00 https://biolegacyresearch.com/warning-letter-roundup-variety-of-gmp-repeat-violations-garner-fda-warnings/ 2017-06-06T16:51:28+00:00 https://biolegacyresearch.com/ema-experts-take-on-brexit-questions/ 2017-06-06T16:53:14+00:00 https://biolegacyresearch.com/483-roundup-repeating-problems-result-in-483s/ 2017-06-06T16:54:55+00:00 https://biolegacyresearch.com/who-updates-its-essential-medicines-list-adding-drugs-for-hep-c-hiv-new-antibiotics/ 2017-06-06T22:22:05+00:00 https://biolegacyresearch.com/mylan-sandoz-teva-and-10-other-generics-makers-named-in-six-price-fixing-lawsuits/ 2017-06-06T22:23:00+00:00 https://biolegacyresearch.com/tennessee-house-speaker-calls-on-states-ag-to-sue-opioid-makers/ 2017-06-06T22:23:50+00:00 https://biolegacyresearch.com/fda-cites-yusef-labs-for-inadequate-investigations-quality-concerns/ 2017-06-06T22:24:40+00:00 https://biolegacyresearch.com/binova-translational-medicine-instituteb-partners-with-bclouderab-to-advance-genome-based-machine-learning-initiatives-and-save-lives/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-loses-4-3-billion-in-market-value-after-asco-update/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/stellar-biotech-expands-operations-team/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/the-1-pharma-stock-that-feels-like-microsoft-in-1986/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/badvantis-corp-b-expanding-national-reach/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/this-small-massachusetts-biotech-soared-to-a-20-month-high-on-its-celgene-partnered-trial/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/medovex-corporation-receives-ce-mark-approval-for-denervex-system/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/debt-ridden-valeant-nears-sale-of-its-2-billion-eye-care-biz-bausch-lomb/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/bmenarinib-expands-its-capabilities-for-antibody-drug-conjugate-adc-projects/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-eases-its-migraine-with-302-million-sale/ 2017-06-07T00:00:00+00:00 https://biolegacyresearch.com/fda-reauthorization-advances-to-house-floor/ 2017-06-07T22:13:00+00:00 https://biolegacyresearch.com/pto-director-michelle-lee-resigns/ 2017-06-07T22:14:36+00:00 https://biolegacyresearch.com/cfda-conducted-fewer-foreign-inspections-in-2016/ 2017-06-07T22:15:30+00:00 https://biolegacyresearch.com/a-major-step-in-the-restoration-of-gut-microbiota-maat-pharma-and-biocodex-to-industrialize-fmt-develop-an-oral-formulation/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/newlink-genetics-stock-plunges-after-genentech-bails-on-1-billion-ido-deal/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/actinium-highlights-presence-at-upcoming-annual-meeting/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/investment-group-just-paid-605-million-for-this-bay-area-pharma/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/merrimack-announces-expansion-of-senior-management-team-with-appointment-of-as-chief-medical-officer-and-as-head-of-human-resources/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-insiders-just-bought-70-million-worth-of-stock-in/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/inspiremd-announces-distribution-agreement-for-cguard-eps-in-taiwan/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/debt-laden-valeant-unloads-inova-pharma-in-930-million-deal/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/chiltern-international-ltd-releases-medidata-rave-value-accelerators-for-capturing-managing-and-reporting-clinical-research-data/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/top-10-life-science-job-trends-in-2017/ 2017-06-08T00:00:00+00:00 https://biolegacyresearch.com/ora-reorganization-includes-new-geographic-divisions-for-devices/ 2017-06-08T20:54:29+00:00 https://biolegacyresearch.com/medical-device-security-is-deeply-lacking-says-new-study/ 2017-06-08T20:56:53+00:00 https://biolegacyresearch.com/australia-follows-fda-and-imdrf-lead-in-regulating-software/ 2017-06-08T21:00:23+00:00 https://biolegacyresearch.com/proposed-fiscal-2018-budget-would-shift-priorities-at-cdrh-ora/ 2017-06-08T21:03:14+00:00 https://biolegacyresearch.com/how-to-detect-trends-in-medical-device-complaints/ 2017-06-08T21:04:46+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-four-firms-for-reporting-documentation/ 2017-06-08T21:06:04+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-hits-devicemakers-over-gmps-validations/ 2017-06-08T21:07:06+00:00 https://biolegacyresearch.com/medical-device-single-audit-program-gains-momentum/ 2017-06-08T21:08:42+00:00 https://biolegacyresearch.com/fda-requests-endo-remove-opioid-painkiller-opana-er-from-the-market-after-reports-of-abuse/ 2017-06-08T21:36:45+00:00 https://biolegacyresearch.com/fda-planning-phased-transition-to-new-cures-act-drug-development-tool-qualification-scheme/ 2017-06-08T21:42:59+00:00 https://biolegacyresearch.com/abpi-reprimands-astellas-uk-and-gedeon-richter-for-publishing-inaccurate-information/ 2017-06-08T21:44:12+00:00 https://biolegacyresearch.com/kph-healthcare-adds-three-companies-to-generics-drug-price-fixing-lawsuits/ 2017-06-08T21:44:55+00:00 https://biolegacyresearch.com/enzo-biochem-reports-increased-revenues-improved-operating-results/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/intuitive-surgical-reports-new-employee-option-grants-for-june-2017/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/bblue-ribbonb-highlights-session-recognizes-best-posters-from-21st-binternational-congress-of-parkinsons-disease-and-movement-disordersb/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/bsaamab-announces-innovative-clinical-data-management-as-a-service-cdaas-solution/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/caris-life-sciences-molecular-intelligence-platform-identifies-patients-with-msi-high-or-mismatch-repair-deficient-solid-tumors-more-likely-to-respond-to-immunotherapy/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/cellect-is-moving-to-trade-exclusively-on-the/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-asks-for-patience-as-takeover-chatter-reemerges-post-asco/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/adherium-appoints-new-ceo-to-drive-global-growth/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/nanthealths-expands-his-empire-with-plans-to-open-a-world-class-cancer-center-this-summer/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/the-single-best-hep-c-drug-stock-to-buy-in-2017mdashhint-its-not-gilead/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/biotelemetry-reaches-key-milestone-in-tender-offer-for-lifewatch-corp/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/effective-immediately-bristol-myers-squibb-exec-to-take-the-reins-at-kleo/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/publication-of-prospectus-relating-to-the-listing-of-on-six-swiss-exchange/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/meet-7-bay-area-scientists-changing-the-face-of-biotech/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/ppd-clinical-research-associates-recognized-for-excellence/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/invacare-proposes-100-million-raise/ 2017-06-09T00:00:00+00:00 https://biolegacyresearch.com/ptab-invalidates-fresenius-patent-on-general-anesthetic-propofol/ 2017-06-09T21:10:30+00:00 https://biolegacyresearch.com/cures-act-left-drug-device-distinction-murky-panel-says/ 2017-06-09T21:11:25+00:00 https://biolegacyresearch.com/tga-plans-to-allow-automatic-instant-approvals-of-lowest-risk-product-variations/ 2017-06-09T21:12:20+00:00 https://biolegacyresearch.com/indias-strides-gets-483-for-quality-problems/ 2017-06-09T21:13:13+00:00 https://biolegacyresearch.com/ose-immunotherapeutics-announces-strategic-multi-year-research-collaboration-with-memorial-sloan-kettering-cancer-center-in-new-york/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/socals-regulus-sinks-after-astrazeneca-plc-bails-on-lead-nash-drug/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/ensysce-biosciences-inc-attending-nih-conference-cutting-edge-science-meeting-series-to-end-the-opioid-crisis-development-of-safe-effective-non-addictive-pain-treatments/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/why-this-tiny-new-jersey-biotech-looks-like-in-1986/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/california-cannabis-growers-now-have-access-to-safe-and-effective-biopesticides-from-marrone-bio-innovations-inc/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/what-biogen-wants-in-return-for-financial-assistance-of-its-750000-a-year-drug/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/exagen-diagnostics-inc-release-improved-laboratory-testing-with-ec4d-can-help-physicians-monitor-patients-with-lupus/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-coherus-craters-after-the-fda-spurns-its-biosimilar-for-amgens-neulasta/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/alnylam-significantly-expands-patent-portfolio-with-new-allowances-from-united-states-patent-and-trademark-office/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/sanofis-rumored-buyout-target-flexion-shows-off-mid-stage-osteoarthritis-data/ 2017-06-12T00:00:00+00:00 https://biolegacyresearch.com/supreme-court-180-day-biosimilar-exclusivity-can-start-any-time-not-just-after-approval/ 2017-06-12T21:11:38+00:00 https://biolegacyresearch.com/one-in-two-out-executive-order-will-likely-increase-use-of-internal-fda-communications/ 2017-06-12T21:12:48+00:00 https://biolegacyresearch.com/mylan-requests-review-of-two-patents-for-sanofis-lantus-insulin/ 2017-06-12T21:13:41+00:00 https://biolegacyresearch.com/fda-rejects-coherus-neulasta-biosimilar-calls-for-new-sample-analyses/ 2017-06-12T21:14:34+00:00 https://biolegacyresearch.com/ema-pharmacovigilance-panel-makes-moves-on-cancer-ms-drugs/ 2017-06-12T21:15:29+00:00 https://biolegacyresearch.com/genenews-announces-repricing-of-gem-warrants/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/deaths-force-merck-co-to-halt-enrollment-for-blood-cancer-studies/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/milestone-scientific-snags-510k-fda-clearance-for-epidural-anesthesia-system/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/meet-the-scientist-finding-success-at-other-biotechs-working-on-old-pfizer-compounds/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/acelity-names-as-chief-financial-officer/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/why-celgene-gets-no-r-e-s-p-e-c-t-but-should/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/taxus-cardium-release-excellagen-receives-notice-of-allowance-for-a-new-patent-application-covering-blood-platelet-activation-endogeneous-growth-factor-release-for-wound-repair-and-tissue-regen/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/human-longevity-co-founder-to-helm-newly-launched-sorrento-spinoff/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/bgrazix-animal-health-inc-b-announces-avians-natural-supplement-for-poultry-new-product-launch-aimed-at-supporting-productivity-in-large-poultry-operations/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-omeros-kidney-disorder-drug-a-breakthrough/ 2017-06-13T00:00:00+00:00 https://biolegacyresearch.com/amgen-defends-neulasta-patent-in-biosimilar-suit-against-coherus/ 2017-06-13T16:55:47+00:00 https://biolegacyresearch.com/fda-drafts-21-new-product-specific-guidances-for-generics-revises-16/ 2017-06-13T16:59:14+00:00 https://biolegacyresearch.com/celltrion-files-two-more-pto-petitions-against-genentechs-herceptin-patents/ 2017-06-13T17:00:36+00:00 https://biolegacyresearch.com/merck-upsher-smith-settle-17-year-pay-for-delay-suit-for-60-million/ 2017-06-13T17:02:02+00:00 https://biolegacyresearch.com/fda-approves-first-strattera-generic-plus-six-other-first-time-approvals/ 2017-06-13T17:04:01+00:00 https://biolegacyresearch.com/members-of-congress-urge-cms-to-set-new-billing-codes-for-biosimilars/ 2017-06-13T17:05:52+00:00 https://biolegacyresearch.com/astellas-sues-roxane-over-generic-copy-of-billion-dollar-drug-xtandi/ 2017-06-13T17:07:23+00:00 https://biolegacyresearch.com/quintilesims-report-drug-spending-growth-slows-to-5-8-in-2016/ 2017-06-13T17:10:19+00:00 https://biolegacyresearch.com/gottlieb-sworn-in-as-fda-commissioner-announces-end-of-hiring-freeze/ 2017-06-13T19:21:03+00:00 https://biolegacyresearch.com/cfda-plans-reforms-in-approvals-and-clinical-trials-processes/ 2017-06-13T19:22:27+00:00 https://biolegacyresearch.com/ec-launches-first-price-gouging-investigation-into-aspen-pharma/ 2017-06-13T19:28:16+00:00 https://biolegacyresearch.com/senate-hearing-on-high-drug-prices-focuses-on-increased-generic-competition-less-on-rd-costs/ 2017-06-13T21:56:51+00:00 https://biolegacyresearch.com/fda-plans-public-workshop-to-evaluate-studies-of-abuse-deterrent-opioid-use/ 2017-06-13T21:57:51+00:00 https://biolegacyresearch.com/supreme-court-to-review-the-constitutionality-of-the-ptos-inter-partes-review/ 2017-06-13T21:59:14+00:00 https://biolegacyresearch.com/aam-report-shows-patients-nearly-three-times-more-likely-to-leave-branded-drugs-at-the-pharmacy/ 2017-06-13T22:00:13+00:00 https://biolegacyresearch.com/fda-seeks-feedback-on-proposed-disclosure-studies-color-additive-rules/ 2017-06-13T22:01:16+00:00 https://biolegacyresearch.com/fda-warns-a-s-medication-solutions-for-inaccurate-drug-listings/ 2017-06-13T22:03:21+00:00 https://biolegacyresearch.com/fda-updates-qas-on-clinical-trials-to-evaluate-potential-heart-rhythm-risks/ 2017-06-14T22:23:49+00:00 https://biolegacyresearch.com/fda-publishes-case-studies-on-biomarker-qualification/ 2017-06-14T22:24:45+00:00 https://biolegacyresearch.com/tga-expands-drug-tampering-recalls-to-arrow-sandoz/ 2017-06-14T22:25:49+00:00 https://biolegacyresearch.com/ptab-invalidates-second-and-third-abbvie-patents-on-humira-dosing-following-coherus-challenges/ 2017-06-14T22:26:50+00:00 https://biolegacyresearch.com/pharma-groups-offer-fixes-to-fdas-outsourcing-regulations/ 2017-06-14T22:27:49+00:00 https://biolegacyresearch.com/appeals-court-revives-wrongful-death-suit-against-teva/ 2017-06-14T22:29:07+00:00 https://biolegacyresearch.com/ipsen-disclosure-of-transactions-in-own-shares-between-05062017-and-09062017/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/what-biogen-cfos-departure-means-for-companys-ma-strategy/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/davita-clinical-research-launches-alliance-site-network-for-early-stage-ckd-trials/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/epizyme-falls-as-investors-take-in-disappointing-phase-ii-data/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/elite-pharma-reports-financial-results-for-the-fiscal-year-ended-march-31-2017-and-provides-conference-call-information/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/new-biotech-incubator-just-opened-up-in-the-big-applemdashwith-room-for-25-startups/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/hologic-receives-expanded-fda-510k-clearance-to-market-cynosures-sculpsure-for-non-invasive-body-contouring-lipolysis-of-back-inner-and-outer-thighs/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/uk-charity-to-use-638-million-cash-from-merck-co-s-blockbuster-keytruda-to-back-rd/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/antibe-therapeutics-announces-filing-of-final-short-form-prospectus/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/googles-verily-and-novartis-ag-jump-into-medicxis-300-million-life-science-investment-fund/ 2017-06-15T00:00:00+00:00 https://biolegacyresearch.com/ptab-to-review-blockbuster-cialis-prevnar-patents/ 2017-06-15T21:49:16+00:00 https://biolegacyresearch.com/nice-to-recommend-kadcyla-kyprolis-for-nhs-funding-but-rejects-besponsa-coverage-before-eu-approval/ 2017-06-15T21:50:06+00:00 https://biolegacyresearch.com/stratus-sonar-shut-down-by-federal-judge/ 2017-06-15T21:50:47+00:00 https://biolegacyresearch.com/connecticut-compounder-warned-on-unsanitary-conditions-and-more/ 2017-06-15T21:51:39+00:00 https://biolegacyresearch.com/prof-inventor-of-abx464-abivaxs-lead-drug-candidate-for-inducing-a-functional-cure-for-hiv-awarded/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/bsonar-productsb-stratus-pharma-ordered-to-cease-operations/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/frost-sullivan-release-evolving-pharmaceutical-ecosystem-transforms-clinical-trials-and-research-outsourcing/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/checkmate-notches-27-million-and-taps-ex-forum-pharma-exec-as-coo/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/otraces-release-beyond-liquid-biopsy-blood-test-can-boost-cancer-detection-diagnosis-with-the-tumor-microenvironment-tme-early-validation-results-reveal-white-paper/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/new-data-reveals-this-new-york-biotechs-pipeline-could-be-a-game-changer/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/celldex-announces-additions-to-the-board-of-directors-and-senior-management-team/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/athenex-a-us-china-cancer-company-stages-66-million-u-s-ipo/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/beyondspring-chief-medical-officer-to-present-clinical-data-for-lead-asset-plinabulin-at-2017-bio-international-convention-in-san-diego/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/ipsen-announces-fda-approval-of-dysport-abobotulinumtoxina-for-the-treatment-of-lower-limb-spasticity-in-adults/ 2017-06-16T00:00:00+00:00 https://biolegacyresearch.com/nevada-governor-signs-diabetes-drug-price-transparency-bill-into-law/ 2017-06-16T21:31:07+00:00 https://biolegacyresearch.com/three-companies-issue-recalls-stemming-from-quality-control-issues/ 2017-06-16T21:31:34+00:00 https://biolegacyresearch.com/ema-postpones-clinical-trials-regulation-to-2019-expects-brexit-relocation-decision-by-october/ 2017-06-16T21:32:44+00:00 https://biolegacyresearch.com/fda-proposes-study-to-improve-dtc-print-ad-disclosures/ 2017-06-16T21:33:04+00:00 https://biolegacyresearch.com/fdas-generic-drugs-office-passes-last-years-record-for-andas-received/ 2017-06-16T21:34:12+00:00 https://biolegacyresearch.com/standardizing-on-veeva-systems-inc-vault-enhances-regenerons-clinical-and-regulatory-operations-processes/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/analgesic-solutions-presents-data-on-the-use-of-madders-to-assess-potentially-abuse-related-events-in-clinical-trials-at-the/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/bclasspassb-raises-70-million-in-series-c-funding-led-by-temasek-life-science-ventures-pte-ltd-tlv-following-its-strongest-quarter-to-date/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/symcel-calorimetry-based-3d-phenotype-assays-a-necessity-for-drug-discovery-and-personalized-medicine/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/bvirginia-c-drososb-president-of-assurex-health-receives-the-ey-entrepreneur-of-the-year-2017-award-in-ohio-valley-region/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/more-deaths-lead-seattle-genetics-to-discontinue-phase-iii-leukemia-study/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/geovax-labs-inc-awarded-nih-grant-for-zika-vaccine/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/warning-these-could-be-the-top-3-most-overrated-biotech-stocks/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/belsevierb-launches-solution-to-accelerate-drug-discovery-through-comprehensive-prediction-and-assessment-of-drug-drug-interactions/ 2017-06-19T00:00:00+00:00 https://biolegacyresearch.com/fda-offers-updated-online-fars-filing-following-successful-pilot-program/ 2017-06-19T21:49:57+00:00 https://biolegacyresearch.com/fda-draft-guidance-calls-for-early-correspondence-to-speed-anda-review/ 2017-06-19T21:50:48+00:00 https://biolegacyresearch.com/fda-calls-for-comments-on-registration-of-outsourcing-compounders/ 2017-06-19T21:51:49+00:00 https://biolegacyresearch.com/fda-approves-adamis-pharmaceuticals-epipen-competitor/ 2017-06-19T21:53:16+00:00 https://biolegacyresearch.com/cbo-scores-fda-user-fee-bill/ 2017-06-19T22:36:31+00:00 https://biolegacyresearch.com/stryker-takes-out-novadaq-corp-in-701-million-deal/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/kibow-biotech-inc-buzz-of-bio-winner-2014-receives-us-patent-for-gouthyperuricemia-product-formulation-based-on-modulation-of-the-gut-microbiome-with-probiotics-and-prebiotics/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/bge-venturesb-bmayo-clinic-venturesb-and-bdfjb-invest-13-75-million-in-first-software-platform-to-accelerate-cancer-cure-process-and-delivery/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/rebiotix-continues-management-team-expansion-with-appointment-of-as-chief-business-officer/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/parexel-sold-to-investment-firm-in-5-billion-deal/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/avexis-announces-proposed-public-offering-of-common-stock/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/biogen-brings-ex-shire-exec-into-c-suite/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/aimmune-presents-european-phase-iii-palisade-screening-data-at-2017-european-academy-of-allergology-and-clinical-immunology-eaaci-congress/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/governor-launches-500-million-initiative-to-keep-massachusetts-biotech-world-booming/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/bserimmuneb-raises-8m-to-map-the-human-antibody-repertoire/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/a-look-at-the-5-most-profitable-biopharma-companies/ 2017-06-20T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-fda-will-clear-backlog-of-orphan-drug-requests-within-90-days/ 2017-06-20T21:34:22+00:00 https://biolegacyresearch.com/fda-updates-part-11-guidance-for-clinical-trials-to-include-mobile-and-wearable-tech/ 2017-06-20T21:35:22+00:00 https://biolegacyresearch.com/fda-advisory-panel-recommends-expanding-victoza-indications-in-reducing-cv-risk/ 2017-06-20T21:36:50+00:00 https://biolegacyresearch.com/opq-planning-to-extend-its-product-quality-benefit-risk-framework/ 2017-06-20T21:37:59+00:00 https://biolegacyresearch.com/china-joins-ich-as-full-regulatory-member-pledges-to-implement-guidelines/ 2017-06-20T21:38:54+00:00 https://biolegacyresearch.com/mithra-pharmaceuticals-launches-a-capital-increase-by-means-of-a-private-placement-via-an-accelerated-bookbuild-offering/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-rejects-proposition-to-create-more-u-s-jobs/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/bdr-ottavio-vitolob-appointed-executive-clinical-advisor-at-relmada-therapeutics/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-biotech-startup-launches-with-23-5-million/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/antibe-therapeutics-announces-closing-of-public-offering/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/money-problems-push-socals-immunocellular-to-suspend-trial-seek-strategic-alternatives/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/isoray-shows-off-another-100-study/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/cambridge-biotech-startup-rubius-banks-120-million-hopes-to-hire-60-new-staffers/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/loxo-oncology-announces-the-closing-of-its-follow-on-offering-of-common-stock-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/tiny-new-york-biotech-with-ties-to-massachusetts-syntimmune-gets-a-50-million-boost/ 2017-06-21T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-plans-to-remove-barriers-to-generics-competition-in-a-bid-to-lower-prices/ 2017-06-21T21:07:01+00:00 https://biolegacyresearch.com/indian-drugmakers-products-banned-from-u-s-market-after-drug-shortage-ends/ 2017-06-21T21:08:00+00:00 https://biolegacyresearch.com/fda-pediatric-cancer-advisory-panel-recommends-moving-away-from-single-agent-studies/ 2017-06-21T21:08:58+00:00 https://biolegacyresearch.com/fda-updating-label-requirements-for-certain-injectables/ 2017-06-21T21:09:42+00:00 https://biolegacyresearch.com/manufacturers-receive-fda-warnings-on-steroids-masquerading-as-supplements/ 2017-06-21T21:10:29+00:00 https://biolegacyresearch.com/nw-bio-closes-3-year-convertible-debt-exchange-and-financing-and-completes-payoff-of-last-5-million-of-2014-bonds/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/amgen-goes-on-the-defensive-when-critics-call-its-pipeline-a-dud/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/alzheon-to-present-novel-molecular-mechanism-of-action-and-long-term-clinical-efficacy-data-for-lead-candidate-alz-801-at/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/15-in-demand-life-science-jobs-in-northern-california/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/bbeijing-4p-health-research-instituteb-initiates-chinas-100k-wellness-pioneer-project-using-unitegen-and-sapientia-integrated-platform/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/brepare-therapeuticsb-bursts-from-stealth-mode-with-68-million-and-a-team-packed-with-industry-alums/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/exactech-expands-presence-in-japan-with-newly-approved-shoulder-knee-and-hip-replacement-systems/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/3-biotech-stocks-that-look-like-apple-did-in-the-1980s/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/bann-romneyb-opens-day-three-of-the-bio-international-convention-with-a-keynote-session/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/insiders-just-bought-234-million-worth-of-these-pharma-stocks/ 2017-06-22T00:00:00+00:00 https://biolegacyresearch.com/senates-healthcare-bill-continues-repeal-of-aca-pharmaceutical-taxes/ 2017-06-22T21:46:19+00:00 https://biolegacyresearch.com/fdas-opq-emerging-tech-program-plans-to-help-sponsors-avoid-manufacturing-quality-failures/ 2017-06-22T21:47:18+00:00 https://biolegacyresearch.com/fda-pediatric-cancer-panel-suggests-more-international-research-collaboration/ 2017-06-22T21:48:21+00:00 https://biolegacyresearch.com/washington-state-compounder-cited-for-unsafe-practices/ 2017-06-22T21:49:14+00:00 https://biolegacyresearch.com/bcros-ntb-launches-croscheck-at-dia-chicago-to-help-clinical-trial-sponsors-meet-new-ich-gcp-e6r2-guidelines/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/genfit-reaches-a-critical-milestone-towards-the-development-of-a-non-invasive-in-vitro-diagnostic-ivd-test-for-nash/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/cardiome-pharma-corp-announces-voting-results/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/feds-accuse-greedy-pharmakon-execs-of-selling-drugs-that-sickened-babies/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/addex-therapeutics-shareholders-approved-all-board-proposals-at-2017-annual-general-meeting/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/5-biotechs-quietly-hitting-unusual-volumes-right-now/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-cara-therapeutics-kidney-disease-drug-a-breakthrough-stock-soars/ 2017-06-23T00:00:00+00:00